Carol A. Tamminga - Publications

Affiliations: 
Department of Psychiatry University of Texas Southwestern Medical Center, Dallas, TX, United States 

371 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Seitz-Holland J, Wojcik JD, Cetin-Karayumak S, Lyall AE, Pasternak O, Rathi Y, Vangel M, Pearlson G, Tamminga C, Sweeney JA, Clementz BA, Schretlen DA, Viher PV, Stegmayer K, Walther S, et al. Cognitive deficits, clinical variables, and white matter microstructure in schizophrenia: a multisite harmonization study. Molecular Psychiatry. PMID 35982257 DOI: 10.1038/s41380-022-01731-3  0.541
2022 Karpouzian-Rogers T, Sweeney JA, Rubin LH, McDowell J, Clementz BA, Gershon E, Keshavan MS, Pearlson GD, Tamminga CA, Reilly JL. Reduced task-evoked pupillary response in preparation for an executive cognitive control response among individuals across the psychosis spectrum. Schizophrenia Research. 248: 79-88. PMID 35963057 DOI: 10.1016/j.schres.2022.07.018  0.535
2022 Türközer HB, Lizano P, Adhan I, Ivleva EI, Lutz O, Zeng V, Zeng A, Raymond N, Bannai D, Lee A, Bishop JR, Clementz BA, Pearlson GD, Sweeney JA, Gershon ES, ... ... Tamminga CA, et al. Regional and Sex-Specific Alterations in the Visual Cortex of Individuals With Psychosis Spectrum Disorders. Biological Psychiatry. PMID 35688762 DOI: 10.1016/j.biopsych.2022.03.023  0.545
2022 Zhang L, Lizano P, Guo B, Xu Y, Rubin LH, Hill SK, Alliey-Rodriguez N, Lee AM, Wu B, Keedy SK, Tamminga CA, Pearlson GD, Clementz BA, Keshavan MS, Gershon ES, et al. Inflammation subtypes in psychosis and their relationships with genetic risk for psychiatric and cardiometabolic disorders. Brain, Behavior, & Immunity - Health. 22: 100459. PMID 35496776 DOI: 10.1016/j.bbih.2022.100459  0.512
2022 Zhao Q, Cao H, Zhang W, Li S, Xiao Y, Tamminga CA, Keshavan MS, Pearlson GD, Clementz BA, Gershon ES, Hill SK, Keedy SK, Ivleva EI, Lencer R, Sweeney JA, et al. A subtype of institutionalized patients with schizophrenia characterized by pronounced subcortical and cognitive deficits. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 35260788 DOI: 10.1038/s41386-022-01300-w  0.537
2022 Tamminga CA, Pearlson G, Gershon E, Keedy S, Hudgens-Haney ME, Ivleva EI, Parker DA, McDowell JE, Clementz B. Using psychosis biotypes and the Framingham model for parsing psychosis biology. Schizophrenia Research. PMID 35123865 DOI: 10.1016/j.schres.2022.01.018  0.808
2021 Rubin LH, Han J, Coughlin JM, Hill SK, Bishop JR, Tamminga CA, Clementz BA, Pearlson GD, Keshavan MS, Gershon ES, Heilman KJ, Porges SW, Sweeney JA, Keedy S. Real-time facial emotion recognition deficits across the psychosis spectrum: A B-SNIP Study. Schizophrenia Research. PMID 34887147 DOI: 10.1016/j.schres.2021.11.027  0.494
2021 Zhang L, Hill SK, Guo B, Wu B, Alliey-Rodriguez NM, Eum S, Lizano PL, Ivleva EI, Reilly JL, Keefe RSE, Keedy SK, Tamminga CA, Pearlson GD, Clementz BA, Keshavan MS, et al. Impact of polygenic risk for coronary artery disease and cardiovascular medication burden on cognitive impairment in psychotic disorders. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 110464. PMID 34756932 DOI: 10.1016/j.pnpbp.2021.110464  0.491
2021 Xiao Y, Liao W, Long Z, Tao B, Zhao Q, Luo C, Tamminga CA, Keshavan MS, Pearlson GD, Clementz BA, Gershon ES, Ivleva EI, Keedy SK, Biswal BB, Mechelli A, et al. Subtyping Schizophrenia Patients Based on Patterns of Structural Brain Alterations. Schizophrenia Bulletin. PMID 34508358 DOI: 10.1093/schbul/sbab110  0.577
2021 Clementz BA, Parker DA, Trotti RL, McDowell JE, Keedy SK, Keshavan MS, Pearlson GD, Gershon ES, Ivleva EI, Huang LY, Hill SK, Sweeney JA, Thomas O, Hudgens-Haney M, Gibbons RD, ... Tamminga CA, et al. Psychosis Biotypes: Replication and Validation from the B-SNIP Consortium. Schizophrenia Bulletin. PMID 34409449 DOI: 10.1093/schbul/sbab090  0.814
2021 Parker DA, Trotti RL, McDowell JE, Keedy SK, Hill SK, Gershon ES, Ivleva EI, Pearlson GD, Keshavan MS, Tamminga CA, Clementz BA. Auditory Oddball Responses Across the Schizophrenia-Bipolar Spectrum and Their Relationship to Cognitive and Clinical Features. The American Journal of Psychiatry. appiajp202120071043. PMID 34407624 DOI: 10.1176/appi.ajp.2021.20071043  0.585
2021 Elad D, Cetin-Karayumak S, Zhang F, Cho KIK, Lyall AE, Seitz-Holland J, Ben-Ari R, Pearlson GD, Tamminga CA, Sweeney JA, Clementz BA, Schretlen DJ, Viher PV, Stegmayer K, Walther S, et al. Improving the predictive potential of diffusion MRI in schizophrenia using normative models-Towards subject-level classification. Human Brain Mapping. PMID 34322947 DOI: 10.1002/hbm.25574  0.496
2021 Gershon ES, Lee SH, Zhou X, Sweeney JA, Tamminga C, Pearlson GA, Clementz BA, Keshavan MS, Alliey-Rodriguez N, Hudgens-Haney M, Keedy SK, Glahn DC, Asif H, Lencer R, Hill SK. An opportunity for primary prevention research in psychotic disorders. Schizophrenia Research. PMID 34315649 DOI: 10.1016/j.schres.2021.07.001  0.813
2021 Guimond S, Gu F, Shannon H, Kelly S, Mike L, Devenyi GA, Chakravarty MM, Sweeney JA, Pearlson G, Clementz BA, Tamminga C, Keshavan M. A Diagnosis and Biotype Comparison Across the Psychosis Spectrum: Investigating Volume and Shape Amygdala-Hippocampal Differences from the B-SNIP Study. Schizophrenia Bulletin. PMID 34254147 DOI: 10.1093/schbul/sbab071  0.507
2021 Eum S, Hill SK, Alliey-Rodriguez N, Stevenson JM, Rubin LH, Lee AM, Mills LJ, Reilly JL, Lencer R, Keedy SK, Ivleva E, Keefe RSE, Pearlson GD, Clementz BA, Tamminga CA, et al. Genome-wide association study accounting for anticholinergic burden to examine cognitive dysfunction in psychotic disorders. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 34145405 DOI: 10.1038/s41386-021-01057-8  0.54
2021 Tricklebank MD, Tamminga C, Grottick A, Llorca PM, Gatti McArthur S, Martel JC. Editorial: Dopaminergic Alterations in Schizophrenia. Frontiers in Neuroscience. 15: 663245. PMID 33776646 DOI: 10.3389/fnins.2021.663245  0.301
2021 Türközer HB, Ivleva EI, Palka J, Clementz BA, Shafee R, Pearlson GD, Sweeney JA, Keshavan MS, Gershon ES, Tamminga CA. Biomarker Profiles in Psychosis Risk Groups Within Unaffected Relatives Based on Familiality and Age. Schizophrenia Bulletin. PMID 33693883 DOI: 10.1093/schbul/sbab013  0.528
2021 Trotti RL, Abdelmageed S, Parker DA, Sabatinelli D, Tamminga CA, Gershon ES, Keedy SK, Keshavan MS, Pearlson GD, Sweeney JA, McDowell JE, Clementz BA. Neural Processing of Repeated Emotional Scenes in Schizophrenia, Schizoaffective Disorder, and Bipolar Disorder. Schizophrenia Bulletin. PMID 33693875 DOI: 10.1093/schbul/sbab018  0.559
2021 Huang LY, Jackson BS, Rodrigue AL, Tamminga CA, Gershon ES, Pearlson GD, Keshavan MS, Keedy SS, Hill SK, Sweeney JA, Clementz BA, McDowell JE. Antisaccade error rates and gap effects in psychosis syndromes from bipolar-schizophrenia network for intermediate phenotypes 2 (B-SNIP2). Psychological Medicine. 1-10. PMID 33622437 DOI: 10.1017/S003329172000478X  0.575
2021 Brown JA, Jackson BS, Burton CR, Hoy JE, Sweeney JA, Pearlson GD, Keshavan MS, Keedy SS, Gershon ES, Tamminga CA, Clementz BA, McDowell JE. Reduced White Matter Microstructure in Bipolar Disorder with and without Psychosis. Bipolar Disorders. PMID 33550654 DOI: 10.1111/bdi.13055  0.52
2021 Frässle S, Harrison SJ, Heinzle J, Clementz BA, Tamminga CA, Sweeney JA, Gershon ES, Keshavan MS, Pearlson GD, Powers A, Stephan KE. Regression dynamic causal modeling for resting-state fMRI. Human Brain Mapping. PMID 33539625 DOI: 10.1002/hbm.25357  0.461
2021 Seitz-Holland J, Cetin-Karayumak S, Wojcik JD, Lyall A, Levitt J, Shenton ME, Pasternak O, Westin CF, Baxi M, Kelly S, Mesholam-Gately R, Vangel M, Pearlson G, Tamminga CA, Sweeney JA, et al. Elucidating the relationship between white matter structure, demographic, and clinical variables in schizophrenia-a multicenter harmonized diffusion tensor imaging study. Molecular Psychiatry. PMID 33483689 DOI: 10.1038/s41380-021-01018-z  0.531
2020 Kelly S, Guimond S, Pasternak O, Lutz O, Lizano P, Cetin-Karayumak S, Sweeney JA, Pearlson G, Clementz BA, McDowell JE, Tamminga CA, Shenton ME, Keshavan MS. White matter microstructure across brain-based biotypes for psychosis - findings from the bipolar-schizophrenia network for intermediate phenotypes. Psychiatry Research. Neuroimaging. 308: 111234. PMID 33385763 DOI: 10.1016/j.pscychresns.2020.111234  0.561
2020 Kelly S, Guimond S, Pasternak O, Lutz O, Lizano P, Cetin-Karayumak S, Sweeney JA, Pearlson G, Clementz BA, McDowell JE, Tamminga CA, Shenton ME, Keshavan MS. White matter microstructure across brain-based biotypes for psychosis - findings from the bipolar-schizophrenia network for intermediate phenotypes. Psychiatry Research. Neuroimaging. 308: 111234. PMID 33385763 DOI: 10.1016/j.pscychresns.2020.111234  0.311
2020 Lizano P, Lutz O, Xu Y, Rubin LH, Paskowitz L, Lee AM, Eum S, Keedy SK, Hill SK, Reilly JL, Wu B, Tamminga CA, Clementz BA, Pearlson GD, Gershon ES, et al. Multivariate relationships between peripheral inflammatory marker subtypes and cognitive and brain structural measures in psychosis. Molecular Psychiatry. PMID 33060818 DOI: 10.1038/s41380-020-00914-0  0.512
2020 Tamminga CA, Clementz BA, Pearlson G, Keshavan M, Gershon ES, Ivleva EI, McDowell J, Meda SA, Keedy S, Calhoun VD, Lizano P, Bishop JR, Hudgens-Haney M, Alliey-Rodriguez N, Asif H, et al. Biotyping in psychosis: using multiple computational approaches with one data set. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 32979849 DOI: 10.1038/s41386-020-00849-8  0.797
2020 Seitz J, Cetin-Karayumak S, Lyall A, Pasternak O, Baxi M, Vangel M, Pearlson G, Tamminga C, Sweeney J, Clementz B, Schretlen D, Viher PV, Stegmayer K, Walther S, Lee J, et al. Investigating Sexual Dimorphism of Human White Matter in a Harmonized, Multisite Diffusion Magnetic Resonance Imaging Study. Cerebral Cortex (New York, N.Y. : 1991). PMID 32851404 DOI: 10.1093/Cercor/Bhaa220  0.493
2020 Hochberger WC, Eskridge CLM, Bishop JR, Reilly JL, Rubin LH, Keedy S, Gershon ES, Tamminga CA, Pearlson GD, Ragozzino M, Keshavan MS, Sweeney JA, Hill SK. Catechol-O-methyltransferase genotype differentially contributes to the flexibility and stability of cognitive sets in patients with psychotic disorders and their first-degree relatives. Schizophrenia Research. PMID 32829984 DOI: 10.1016/J.Schres.2020.08.005  0.377
2020 Okuneye VT, Meda S, Pearlson GD, Clementz BA, Keshavan MS, Tamminga CA, Ivleva E, Sweeney JA, Gershon ES, Keedy SK. Resting state auditory-language cortex connectivity is associated with hallucinations in clinical and biological subtypes of psychotic disorders. Neuroimage. Clinical. 27: 102358. PMID 32745995 DOI: 10.1016/J.Nicl.2020.102358  0.539
2020 Gotra MY, Hill SK, Gershon ES, Tamminga CA, Ivleva EI, Pearlson GD, Keshavan MS, Clementz BA, McDowell JE, Buckley PF, Sweeney JA, Keedy SK. Distinguishing patterns of impairment on inhibitory control and general cognitive ability among bipolar with and without psychosis, schizophrenia, and schizoaffective disorder. Schizophrenia Research. PMID 32674921 DOI: 10.1016/J.Schres.2020.06.033  0.621
2020 Herms EN, Bishop JR, Okuneye VT, Tamminga CA, Keshavan MS, Pearlson GD, Clementz BA, McDowell JE, Ivleva EI, Gershon ES, Sweeney JA, Keedy SK. No connectivity alterations for striatum, default mode, or salience network in association with self-reported antipsychotic medication dose in a large chronic patient group. Schizophrenia Research. PMID 32624351 DOI: 10.1016/J.Schres.2020.06.017  0.506
2020 Clementz BA, Trotti RL, Pearlson GD, Keshavan MS, Gershon ES, Keedy SK, Ivleva EI, McDowell JE, Tamminga CA. Testing Psychosis Phenotypes From Bipolar-Schizophrenia Network for Intermediate Phenotypes for Clinical Application: Biotype Characteristics and Targets. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. PMID 32600898 DOI: 10.1016/J.Bpsc.2020.03.011  0.602
2020 Fountoulakis KN, Moeller HJ, Kasper S, Tamminga C, Yamawaki S, Kahn R, Tandon R, Correll CU, Javed A. The report of the joint WPA/CINP workgroup on the use and usefulness of antipsychotic medication in the treatment of schizophrenia. Cns Spectrums. 1-75. PMID 32594935 DOI: 10.1017/S1092852920001546  0.356
2020 Zeng V, Lizano P, Bolo NR, Lutz O, Brady R, Ivleva EI, Dai W, Clementz B, Tamminga C, Pearlson G, Keshavan M. Altered Cerebral Perfusion in Bipolar Disorder: A pCASL MRI Study. Bipolar Disorders. PMID 32583570 DOI: 10.1111/Bdi.12966  0.573
2020 Lutz O, Lizano P, Mothi SS, Zeng V, Hegde RR, Hoang DT, Henson P, Brady R, Tamminga CA, Pearlson G, Clementz BA, Sweeney JA, Keshavan MS. Do neurobiological differences exist between paranoid and non-paranoid schizophrenia? Findings from the bipolar schizophrenia network on intermediate phenotypes study. Schizophrenia Research. PMID 32507376 DOI: 10.1016/J.Schres.2020.02.011  0.578
2020 Kane JM, Vanover KE, Durgam S, Davis R, Satlin A, Rowe W, Mates S, Tamminga C. 185 The Safety and Tolerability of Lumateperone 42 mg for the Treatment of Schizophrenia: A Pooled Analysis of 3 Randomized Placebo-Controlled Trials. Cns Spectrums. 25: 316-317. PMID 32331042 DOI: 10.1017/S1092852920001005  0.337
2020 Perez JM, Berto S, Gleason K, Ghose S, Tan C, Kim TK, Konopka G, Tamminga CA. Hippocampal subfield transcriptome analysis in schizophrenia psychosis. Molecular Psychiatry. PMID 32152472 DOI: 10.1038/S41380-020-0696-6  0.349
2020 Bannai D, Lizano P, Kasetty M, Lutz O, Zeng V, Sarvode S, Kim LA, Hill S, Tamminga C, Clementz B, Gershon E, Pearlson G, Miller JB, Keshavan M. Retinal layer abnormalities and their association with clinical and brain measures in psychotic disorders: A preliminary study. Psychiatry Research. Neuroimaging. 299: 111061. PMID 32145500 DOI: 10.1016/J.Pscychresns.2020.111061  0.52
2020 Asif H, Alliey-Rodriguez N, Keedy S, Tamminga CA, Sweeney JA, Pearlson G, Clementz BA, Keshavan MS, Buckley P, Liu C, Neale B, Gershon ES. GWAS significance thresholds for deep phenotyping studies can depend upon minor allele frequencies and sample size. Molecular Psychiatry. PMID 32066829 DOI: 10.1038/S41380-020-0670-3  0.483
2020 Hudgens-Haney ME, Clementz BA, Ivleva EI, Keshavan MS, Pearlson GD, Gershon ES, Keedy SK, Sweeney JA, Gaudoux F, Bunouf P, Canolle B, Tonner F, Gatti-McArthur S, Tamminga CA. Cognitive Impairment and Diminished Neural Responses Constitute a Biomarker Signature of Negative Symptoms in Psychosis. Schizophrenia Bulletin. PMID 32043133 DOI: 10.1093/schbul/sbaa001  0.796
2020 Blackburn KM, Ivleva EI, Weir RA, Kim M, Hopkins SC, Hudgens-Haney ME, Keedy SK, Gershon ES, Sweeney JA, Keshavan MS, Pearlson GD, Clementz BA, Tamminga CA, Vernino S. NMDA receptor antibody seropositivity in psychosis: A pilot study from the Bipolar-Schizophrenia Network for Intermediate Phenotypes (B-SNIP). Schizophrenia Research. PMID 31952910 DOI: 10.1016/J.Schres.2020.01.004  0.804
2020 Correll CU, Davis RE, Weingart M, Saillard J, O'Gorman C, Kane JM, Lieberman JA, Tamminga CA, Mates S, Vanover KE. Efficacy and Safety of Lumateperone for Treatment of Schizophrenia: A Randomized Clinical Trial. Jama Psychiatry. PMID 31913424 DOI: 10.1001/Jamapsychiatry.2019.4379  0.402
2020 del Re EC, Zeng V, Lutz O, Pearlson G, Sweeney J, Clementz B, Gershon ES, Keedy S, Ivleva E, Tamminga C, Keshavan M. O10.6. ANTERIOR VERSUS POSTERIOR HIPPOCAMPUS WITHIN PSYCHOSIS: A BSNIP STUDY Schizophrenia Bulletin. 46: S26-S27. DOI: 10.1093/Schbul/Sbaa028.060  0.581
2020 Clementz B, Trotti R, Pearlson GD, Keshavan M, Gershon E, Keedy S, Ivleva E, McDowell JE, Tamminga C. O3.4. PSYCHOSIS PHENOTYPES FROM B-SNIP FOR CLINICAL ADVANCES: BIOTYPE CHARACTERISTICS AND TARGETS Schizophrenia Bulletin. 46: S7-S7. DOI: 10.1093/Schbul/Sbaa028.015  0.588
2020 Okuneye V, Clementz B, Gershon E, Keshavan M, McDowell JE, Pearlson G, Tamminga C, Sweeney J, Keedy S. O2.6. DELUSIONS ASSOCIATED WITH ABNORMAL FRONTOSTRIATAL EFFECTIVE CONNECTIVITY IN A SPECTRAL DCM ANALYSIS OF RESTING STATE FMRI Schizophrenia Bulletin. 46: S5-S5. DOI: 10.1093/Schbul/Sbaa028.011  0.55
2020 Abdelmageed S, Trotti R, Parker D, Sabatinelli D, Tamminga C, Gershon E, Keedy S, Sweeney JA, Keshavan MS, Pearlson G, McDowell JE, Clementz BA. Effects of Stimulus Repetition on Emotional Processing in Psychosis Biotypes: Findings From Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) Consortium Biological Psychiatry. 87: S389. DOI: 10.1016/J.Biopsych.2020.02.996  0.592
2020 Zeng V, Lizano P, Hegde R, Lutz O, Hoang D, Adhan I, Nisenson M, Raymond N, Lai M, Bannai D, Tamminga C, Clementz B, Pearlson G, Sweeney J, Keshavan M. Thalamic Nuclei Reductions Across the Psychosis Spectrum: A BSNIP Study Biological Psychiatry. 87. DOI: 10.1016/J.Biopsych.2020.02.881  0.523
2020 del Re EC, Zeng V, Chen C, Blokland G, Lutz O, Pearlson G, Sweeney JA, Clementz B, Gershon E, Keedy S, Ivleva EI, Tamminga C, Keshavan M. Genetic Topography of Cortical thickness: A BSNIP Study Biological Psychiatry. 87: S293. DOI: 10.1016/J.Biopsych.2020.02.756  0.473
2020 Turkozer HB, Lizano P, Adhan I, Ivleva EI, Lutz O, Zeng A, Raymond N, Clementz BA, Pearlson G, Sweeney J, Gershon E, Keshavan M, Tamminga C. Neuroanatomical Sex Differences in the Visual Cortex of Individuals With Psychosis: Findings From the Bipolar-Schizophrenia Network on Intermediate Phenotypes Biological Psychiatry. 87: S205. DOI: 10.1016/J.Biopsych.2020.02.533  0.603
2020 Mendizabal I, Berto S, Usui N, Toriumi K, Chatterjee P, Douglas C, Huh I, Jeong H, Layman T, Tamminga C, Preuss T, Konopka G, Yi S. Cell-Type Specific Epigenetic Links to Schizophrenia Risk in Control and Patients Biological Psychiatry. 87. DOI: 10.1016/J.Biopsych.2020.02.176  0.371
2020 Trotti R, Parker D, Tamminga C, Pearlson G, Keshavan M, Keedy S, Gershon E, McDowell JE, Clementz B. Longitudinal Stability of EEG Psychosis Biomarkers: Findings From the Bipolar-Schizophrenia Network for Intermediate Phenotypes (B-SNIP) Biological Psychiatry. 87: S409-S410. DOI: 10.1016/J.Biopsych.2020.02.1045  0.61
2020 Salsman M, Ivleva EI, Pearlson GD, Keshavan MS, Gershon E, Keedy S, Sweeney JA, Clementz BA, Tamminga CA, Hudgens-Haney M. Intrinsic Activity Networks Differentiate Psychosis Biotypes Biological Psychiatry. 87: S406-S407. DOI: 10.1016/J.Biopsych.2020.02.1038  0.771
2020 Parker DA, Trotti RL, McDowell JE, Keedy SK, Gershon ES, Ivleva EI, Pearlson GD, Keshavan MS, Tamminga CA, Sweeney JA, Clementz BA. Auditory paired-stimuli responses across the psychosis and bipolar spectrum and their relationship to clinical features Biomarkers in Neuropsychiatry. 3: 100014. DOI: 10.1016/j.bionps.2020.100014  0.456
2019 Stan AD, Tamminga CA, Han K, Kim JB, Padmanabhan J, Tandon N, Hudgens-Haney ME, Keshavan MS, Clementz BA, Pearlson GD, Sweeney JA, Gibbons RD. Associating Psychotic Symptoms with Altered Brain Anatomy in Psychotic Disorders Using Multidimensional Item Response Theory Models. Cerebral Cortex (New York, N.Y. : 1991). PMID 31813988 DOI: 10.1093/Cercor/Bhz285  0.799
2019 Zhang W, Du L, Keedy SK, Ivleva EI, Eum S, Yao L, Tamminga CA, Clementz BA, Keshavan MS, Pearlson GD, Gershon ES, Bishop JR, Gong Q, Lui S, Sweeney JA. Brain gray matter network organization in psychotic disorders. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 31812151 DOI: 10.1038/S41386-019-0586-2  0.627
2019 Massa N, Owens AV, Harmon W, Bhattacharya A, Ivleva EI, Keedy S, Sweeney JA, Pearlson GD, Keshavan MS, Tamminga CA, Clementz BA, Duncan E. Relationship of prolonged acoustic startle latency to diagnosis and biotype in the bipolar-schizophrenia network on intermediate phenotypes (B-SNIP) cohort. Schizophrenia Research. PMID 31796306 DOI: 10.1016/J.Schres.2019.11.013  0.639
2019 Brakemeier S, Sprenger A, Meyhöfer I, McDowell JE, Rubin LH, Hill SK, Keshavan MS, Pearlson GD, Tamminga CA, Gershon ES, Keedy SS, Sweeney JA, Clementz BA, Lencer R. Smooth pursuit eye movement deficits as a biomarker for psychotic features in bipolar disorder - Findings from the PARDIP study. Bipolar Disorders. PMID 31721386 DOI: 10.1111/Bdi.12865  0.598
2019 Berto S, Mendizabal I, Usui N, Toriumi K, Chatterjee P, Douglas C, Tamminga CA, Preuss TM, Yi SV, Konopka G. Accelerated evolution of oligodendrocytes in the human brain. Proceedings of the National Academy of Sciences of the United States of America. PMID 31712436 DOI: 10.1073/Pnas.1907982116  0.33
2019 Trotti RL, Parker DA, Sabatinelli D, Tamminga CA, Gershon ES, Keedy SK, Keshavan MS, Pearlson GD, Sweeney JA, McDowell JE, Clementz BA. Electrophysiological correlates of emotional scene processing in bipolar disorder. Journal of Psychiatric Research. 120: 83-90. PMID 31634753 DOI: 10.1016/J.Jpsychires.2019.10.005  0.525
2019 Dai W, Chen M, Duan W, Zhao L, Bolo NR, Tamminga C, Clementz BA, Pearlson GD, Alsop DC, Keshavan M. Abnormal Perfusion Fluctuation and Perfusion Connectivity in Bipolar Disorder Measured by Dynamic Arterial Spin Labeling. Bipolar Disorders. PMID 31630476 DOI: 10.1111/Bdi.12856  0.514
2019 Tamminga CA, Clementz BA. Biological fingerprints for psychosis. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 31558770 DOI: 10.1038/S41386-019-0505-6  0.549
2019 Alliey-Rodriguez N, Grey TA, Shafee R, Asif H, Lutz O, Bolo NR, Padmanabhan J, Tandon N, Klinger M, Reis K, Spring J, Coppes L, Zeng V, Hegde RR, Hoang DT, ... ... Tamminga C, et al. NRXN1 is associated with enlargement of the temporal horns of the lateral ventricles in psychosis. Translational Psychiatry. 9: 230. PMID 31530798 DOI: 10.1038/S41398-019-0564-9  0.566
2019 Cetin-Karayumak S, Di Biase MA, Chunga N, Reid B, Somes N, Lyall AE, Kelly S, Solgun B, Pasternak O, Vangel M, Pearlson G, Tamminga C, Sweeney JA, Clementz B, Schretlen D, et al. White matter abnormalities across the lifespan of schizophrenia: a harmonized multi-site diffusion MRI study. Molecular Psychiatry. PMID 31511636 DOI: 10.1038/S41380-019-0509-Y  0.577
2019 Ji L, Meda SA, Tamminga CA, Clementz BA, Keshavan MS, Sweeney JA, Gershon ES, Pearlson GD. Characterizing functional regional homogeneity (ReHo) as a B-SNIP psychosis biomarker using traditional and machine learning approaches. Schizophrenia Research. PMID 31439419 DOI: 10.1016/J.Schres.2019.07.015  0.541
2019 Mendizabal I, Berto S, Usui N, Toriumi K, Chatterjee P, Douglas C, Huh I, Jeong H, Layman T, Tamminga CA, Preuss TM, Konopka G, Yi SV. Cell type-specific epigenetic links to schizophrenia risk in the brain. Genome Biology. 20: 135. PMID 31288836 DOI: 10.1186/S13059-019-1747-7  0.392
2019 Bobilev AM, Perez JM, Tamminga CA. Molecular alterations in the medial temporal lobe in schizophrenia. Schizophrenia Research. PMID 31227207 DOI: 10.1016/J.Schres.2019.06.001  0.415
2019 Lizano P, Lutz O, Ling G, Lee AM, Eum S, Bishop JR, Kelly S, Pasternak O, Clementz B, Pearlson G, Sweeney JA, Gershon E, Tamminga C, Keshavan M. Association of Choroid Plexus Enlargement With Cognitive, Inflammatory, and Structural Phenotypes Across the Psychosis Spectrum. The American Journal of Psychiatry. appiajp201918070825. PMID 31164007 DOI: 10.1176/Appi.Ajp.2019.18070825  0.601
2019 Ji JL, Diehl C, Schleifer C, Tamminga CA, Keshavan MS, Sweeney JA, Clementz BA, Hill SK, Pearlson G, Yang G, Creatura G, Krystal JH, Repovs G, Murray J, Winkler A, et al. Schizophrenia Exhibits Bi-directional Brain-Wide Alterations in Cortico-Striato-Cerebellar Circuits. Cerebral Cortex (New York, N.Y. : 1991). PMID 31157363 DOI: 10.1093/Cercor/Bhy306  0.596
2019 Parker DA, Hamm JP, McDowell JE, Keedy SK, Gershon ES, Ivleva EI, Pearlson GD, Keshavan MS, Tamminga CA, Sweeney JA, Clementz BA. Auditory steady-state EEG response across the schizo-bipolar spectrum. Schizophrenia Research. PMID 31080153 DOI: 10.1016/J.Schres.2019.04.014  0.579
2019 Nucifora LG, MacDonald ML, Lee BJ, Peters ME, Norris AL, Orsburn BC, Yang K, Gleason K, Margolis RL, Pevsner J, Tamminga CA, Sweet RA, Ross CA, Sawa A, Nucifora FC. Increased Protein Insolubility in Brains From a Subset of Patients With Schizophrenia. The American Journal of Psychiatry. appiajp201918070864. PMID 31055969 DOI: 10.1176/Appi.Ajp.2019.18070864  0.423
2019 Reininghaus U, Böhnke JR, Chavez-Baldini U, Gibbons R, Ivleva E, Clementz BA, Pearlson GD, Keshavan MS, Sweeney JA, Tamminga CA. Transdiagnostic dimensions of psychosis in the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP). World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 18: 67-76. PMID 30600629 DOI: 10.1002/Wps.20607  0.609
2019 Clementz B, Hudgens-Haney M, Pearlson G, Keshavan M, Sweeney J, Gershon E, Tamminga C, Keedy S, Ivleva E. 10.3 INTRINSIC NEURAL ACTIVITY AS A BIOMARKER FOR DIFFERENTIAL TREATMENT EFFICACY IN PSYCHOSIS Schizophrenia Bulletin. 45: S103-S103. DOI: 10.1093/Schbul/Sbz022.036  0.773
2019 Kelly S, Guimond S, Pasternak O, Lutz O, Sweeney JA, Pearlson G, Clementz B, Tamminga C, Shenton ME, Keshavan M. O11.4. DIAGNOSIS AND BIOTYPE COMPARISON ACROSS THE PSYCHOSIS SPECTRUM: INVESTIGATING WHITE MATTER MICROSTRUCTURAL DIFFERENCES FROM THE BIPOLAR-SCHIZOPHRENIA NETWORK ON INTERMEDIATE PHENOTYPES (B-SNIP) STUDY USING FREE-WATER IMAGING Schizophrenia Bulletin. 45: S195-S195. DOI: 10.1093/Schbul/Sbz021.260  0.589
2019 Trotti R, Parker D, Sabatinelli D, Tamminga C, Gershon E, Keedy S, Sweeney J, Keshavan M, Pearlson G, McDowell JE, Clementz B. O9.5. EMOTIONAL SCENE PROCESSING IN PSYCHOSIS BIOTYPES: FINDINGS FROM THE BIPOLAR-SCHIZOPHRENIA NETWORK ON INTERMEDIATE PHENOTYPES (BSNIP) Schizophrenia Bulletin. 45: S188-S188. DOI: 10.1093/Schbul/Sbz021.245  0.581
2019 Nucifora L, MacDonald M, Lee B, Peters M, Norris A, Orsburn BO, Gleason K, Yang K, Margolis R, Pevsner J, Tamminga C, Sweet R, Ross C, Sawa A, Nucifora F. O2.3. Increased Protein Insolubility In Brains From A Subset Of Patients With Schizophrenia Schizophrenia Bulletin. 45. DOI: 10.1093/Schbul/Sbz021.187  0.37
2019 Alliey N, Rubin D, Asif H, Hudgens-Haney M, Clementz BA, Pearlson GD, Keshavan MS, Sweeney JA, Tamminga C, Keedy S, Gershon E. T47Brain Angiogenesis Inhibitor Gene Is Associated With Modifications Of Event Response Potentials In Psychosis European Neuropsychopharmacology. 29. DOI: 10.1016/J.Euroneuro.2019.08.246  0.483
2019 Alliey N, Gershon E, Grey TA, Shafee R, Tandon N, Coppes L, Keedy S, McCarroll S, Pearlson G, Keshavan M, Clementz BA, Tamminga C. COMMON VARIANTS OF NRXN1, LRP1B AND RORA ARE ASSOCIATED WITH INCREASED VENTRICULAR VOLUMES IN SCHIZOPHRENIA AND BIPOLAR DISORDER European Neuropsychopharmacology. 29: S924-S925. DOI: 10.1016/J.Euroneuro.2017.08.257  0.612
2019 Lutz O, Hegde R, Henson P, Hoang J, Zeng V, Tamminga C, Clementz B, Pearlson G, Sweeney JA, Lizano P, Keshavan M. S162. Widespread Amygdala Nuclei Reductions Across the Psychosis Spectrum and in Their First-Degree Relatives: A BSNIP Study Biological Psychiatry. 85. DOI: 10.1016/J.Biopsych.2019.03.913  0.515
2019 Turkozer HB, Ivleva EI, Clementz BA, Pearlson GD, Sweeney JA, Keshavan MS, Gershon E, Tamminga CA. F185. The B-SNIP Biomarker Profiles in Clinically-Unaffected Relatives: Contributions of a Subjective Family History Report Biological Psychiatry. 85: S285. DOI: 10.1016/J.Biopsych.2019.03.722  0.49
2019 Nucifora L, MacDonald M, Lee B, Peters M, Norris A, Orsburn B, Yang K, Gleason K, Margolis R, Pevsner J, Tamminga C, Sweet R, Ross C, Sawa A, Nucifora F. F168. Increased Protein Insolubility in Brains From a Subset of Patients With Schizophrenia Biological Psychiatry. 85. DOI: 10.1016/J.Biopsych.2019.03.705  0.366
2019 Lizano P, Kasetty M, Zeng R, Wang J, Diaz D, Lutz O, Zeng V, Sweeney JA, Clementz B, Tamminga C, Keshavan M. T176. Examining Retinal Nerve Fiber Layer Thickness and Microvascular Abnormalities in Psychosis With Swept Source OCT and OCT-A Biological Psychiatry. 85. DOI: 10.1016/J.Biopsych.2019.03.499  0.466
2019 Lutz O, Hegde R, Henson P, Hoang J, Zeng V, Tamminga C, Clementz B, Pearlson G, Sweeney J, Lizano P, Keshavan M. T173. Structural Amygdala Nuclei Abnormalities Distinguish Neurobiologically Derived Biotypes With Psychosis Biological Psychiatry. 85. DOI: 10.1016/J.Biopsych.2019.03.496  0.5
2019 Asif H, Alliey-Rodriguez N, Keedy S, Tamminga C, Pearlson GD, Clementz BA, Keshavan M, Buckley P, Neale B, Gershon E. T170. Effective Multiple Test Correction (MTC) for GWAS With Large Numbers of Correlated Genotypes and Phenotypes Biological Psychiatry. 85: S195. DOI: 10.1016/J.Biopsych.2019.03.493  0.472
2019 Thomas O, Parker D, Trotti R, McDowell J, Gershon E, Sweeney J, Keshavan MS, Keedy SK, Ivleva E, Tamminga CA, Pearlson GD, Clementz BA. Intrinsic neural activity differences in psychosis biotypes: Findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) consortium Biomarkers in Neuropsychiatry. 1: 100002. DOI: 10.1016/j.bionps.2019.100002  0.319
2018 Clementz BA, Sweeney JA, Hamm JP, Ivleva EI, Ethridge LE, Pearlson GD, Keshavan MS, Tamminga CA. Identification of Distinct Psychosis Biotypes Using Brain-Based Biomarkers. Focus (American Psychiatric Publishing). 16: 225-236. PMID 32015710 DOI: 10.1176/appi.focus.16207  0.47
2018 Rubin LH, Li S, Yao L, Keedy SK, Reilly JL, Hill SK, Bishop JR, Sue Carter C, Pournajafi-Nazarloo H, Drogos LL, Gershon E, Pearlson GD, Tamminga CA, Clementz BA, Keshavan MS, et al. Peripheral oxytocin and vasopressin modulates regional brain activity differently in men and women with schizophrenia. Schizophrenia Research. 202: 173-179. PMID 30539769 DOI: 10.1016/j.schres.2018.07.003  0.615
2018 Lizano P, Lutz O, Ling G, Padmanabhan J, Tandon N, Sweeney J, Tamminga C, Pearlson G, Ruaño G, Kocherla M, Windemuth A, Clementz B, Gershon E, Keshavan M. VEGFA GENE variation influences hallucinations and frontotemporal morphology in psychotic disorders: a B-SNIP study. Translational Psychiatry. 8: 215. PMID 30310054 DOI: 10.1038/S41398-018-0271-Y  0.583
2018 Lencer R, Yao L, Reilly JL, Keedy SK, McDowell JE, Keshavan MS, Pearlson GD, Tamminga CA, Gershon ES, Clementz BA, Lui S, Sweeney JA. Alterations in intrinsic fronto-thalamo-parietal connectivity are associated with cognitive control deficits in psychotic disorders. Human Brain Mapping. PMID 30260540 DOI: 10.1002/Hbm.24362  0.582
2018 van der Doef TF, Domingo SZ, Jacobs GE, Drevets WC, Marston HM, Nathan PJ, Tome MB, Tamminga CA, van Gerven JMA, Kas MJH. New approaches in psychiatric drug development. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 30056086 DOI: 10.1016/J.Euroneuro.2018.06.006  0.317
2018 Segev A, Yanagi M, Scott D, Southcott SA, Lister JM, Tan C, Li W, Birnbaum SG, Kourrich S, Tamminga CA. Reduced GluN1 in mouse dentate gyrus is associated with CA3 hyperactivity and psychosis-like behaviors. Molecular Psychiatry. PMID 30038231 DOI: 10.1038/S41380-018-0124-3  0.461
2018 Mothi SS, Sudarshan M, Tandon N, Tamminga C, Pearlson G, Sweeney J, Clementz B, Keshavan MS. Machine learning improved classification of psychoses using clinical and biological stratification: Update from the bipolar-schizophrenia network for intermediate phenotypes (B-SNIP). Schizophrenia Research. PMID 29807804 DOI: 10.1016/J.Schres.2018.04.037  0.575
2018 Rodrigue AL, McDowell JE, Tandon N, Keshavan MS, Tamminga CA, Pearlson GD, Sweeney JA, Gibbons RD, Clementz BA. Multivariate Relationships Between Cognition and Brain Anatomy Across the Psychosis Spectrum. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. PMID 29759822 DOI: 10.1016/J.Bpsc.2018.03.012  0.541
2018 Shafee R, Nanda P, Padmanabhan JL, Tandon N, Alliey-Rodriguez N, Kalapurakkel S, Weiner DJ, Gur RE, Keefe RSE, Hill SK, Bishop JR, Clementz BA, Tamminga CA, Gershon ES, Pearlson GD, et al. Polygenic risk for schizophrenia and measured domains of cognition in individuals with psychosis and controls. Translational Psychiatry. 8: 78. PMID 29643358 DOI: 10.1038/S41398-018-0124-8  0.629
2018 Abush H, Ghose S, Van Enkevort EA, Clementz BA, Pearlson GD, Sweeney JA, Keshavan MS, Tamminga CA, Ivleva EI. Associations between adolescent cannabis use and brain structure in psychosis. Psychiatry Research. PMID 29628270 DOI: 10.1016/J.Pscychresns.2018.03.008  0.61
2018 Akinhanmi MO, Biernacka JM, Strakowski SM, McElroy SL, Balls Berry JE, Merikangas KR, Assari S, McInnis MG, Schulze TG, LeBoyer M, Tamminga C, Patten C, Frye MA. Racial disparities in bipolar disorder treatment and research: a call to action. Bipolar Disorders. PMID 29527766 DOI: 10.1111/Bdi.12638  0.329
2018 Amaral DG, Anderson MP, Ansorge O, Chance S, Hare C, Hof PR, Miller M, Nagakura I, Pickett J, Schumann C, Tamminga C. Autism BrainNet: A network of postmortem brain banks established to facilitate autism research. Handbook of Clinical Neurology. 150: 31-39. PMID 29496150 DOI: 10.1016/B978-0-444-63639-3.00003-7  0.33
2018 Chen J, Calhoun VD, Lin D, Perrone-Bizzozero NI, Bustillo JR, Pearlson GD, Potkin SG, van Erp TGM, Macciardi F, Ehrlich S, Ho BC, Sponheim SR, Wang L, Stephen JM, Mayer AR, ... ... Tamminga CA, et al. Shared Genetic Risk of Schizophrenia and Gray Matter Reduction in 6p22.1. Schizophrenia Bulletin. PMID 29474680 DOI: 10.1093/Schbul/Sby010  0.558
2018 Gonzalez R, Suppes T, Zeitzer J, McClung C, Tamminga C, Tohen M, Forero A, Dwivedi A, Alvarado A. The association between mood state and chronobiological characteristics in bipolar I disorder: a naturalistic, variable cluster analysis-based study. International Journal of Bipolar Disorders. 6: 5. PMID 29457195 DOI: 10.1186/S40345-017-0113-5  0.32
2018 Guimond S, Tingue S, Devenyi GA, Tang Y, Mike L, Mallar Chakravarty M, Sweeney JA, Pearlson GD, Clementz BA, Tamminga CA, Keshavan MS. T22. PITUITARY GLAND VOLUME DIFFERENCES IN INDIVIDUALS WITH PSYCHOSIS: RESULTS FROM THE BIPOLAR-SCHIZOPHRENIA NETWORK ON INTERMEDIATE PHENOTYPES (B-SNIP) STUDY Schizophrenia Bulletin. 44: S121-S121. DOI: 10.1093/Schbul/Sby016.298  0.603
2018 Clementz B, Pearlson G, Tamminga C, Sweeney J, Keshavan M. 9.3 PSYCHOSIS BIOTYPES VERSUS CLINICAL SYNDROMES THROUGH THE PRISM OF INTRINSIC NEURAL ACTIVITY Schizophrenia Bulletin. 44: S14-S14. DOI: 10.1093/Schbul/Sby014.031  0.513
2018 Reininghaus U, Boehnke J, Chavez-Baldini U, Clementz B, Pearlson G, Keshavan M, Sweeney J, Tamminga C. 5.3 EVIDENCE ON A TRANSDIAGNOSTIC PSYCHOSIS SPECTRUM OF SCHIZOPHRENIA, SCHIZOAFFECTIVE AND PSYCHOTIC BIPOLAR DISORDER IN THE BIPOLAR-SCHIZOPHRENIA NETWORK ON INTERMEDIATE PHENOTYPES (B-SNIP) Schizophrenia Bulletin. 44: S6-S7. DOI: 10.1093/Schbul/Sby014.015  0.633
2018 Scott D, Tan C, Yanagi M, Tamminga CA. F190. Hippocampal Subfield Activity May Mediate Aspects of Psychosis Biological Psychiatry. 83: S312-S313. DOI: 10.1016/J.Biopsych.2018.02.804  0.433
2018 Parker D, Trotti R, McDowell JE, Keedy S, Sweeney J, Gershon E, Pearlson G, Keshavan M, Tamminga C, Clementz B. 148. Auditory and Visual EEG Validators of Psychosis Biotypes, Findings From Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) Consortium Biological Psychiatry. 83: S60-S61. DOI: 10.1016/J.Biopsych.2018.02.166  0.597
2018 Meda S, Clementz B, Sweeney J, Keshavan M, Tamminga C, Ivleva EI, Pearlson G. 147. Resting State Connectivity in Traditional and Biologically Derived B-SNIP Psychosis Subtypes Biological Psychiatry. 83: S60. DOI: 10.1016/J.Biopsych.2018.02.165  0.516
2018 Kelly S, Guimond S, Sweeney J, Pearlson G, Clementz B, Tamminga C, Shenton M, Pasternak O, Keshavan M. 146. Diagnosis and Biotype Comparisons Across the Psychosis Spectrum: Investigating White Matter Microstructural Differences From the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) Study Using Free-Water Imaging Biological Psychiatry. 83: S59-S60. DOI: 10.1016/J.Biopsych.2018.02.164  0.598
2018 Guimond S, Kelly S, Mike L, Chakravarty MM, Sweeney J, Pearlson G, Clementz BA, Tamminga C, Keshavan M. 145. Diagnosis and Biotype Comparisons Across the Psychosis Spectrum: Investigating Amygdala-Hippocampal Differences From the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) Study Biological Psychiatry. 83: S59. DOI: 10.1016/J.Biopsych.2018.02.163  0.616
2018 Clementz B, Stan A, Pearlson G, Sweeney J, Keshavan M, Tamminga CA, Gibbons R. 108. Consolidation Across Multiple Levels of Analysis for Parsing Biological Heterogeneity in Psychosis Biological Psychiatry. 83: S44-S45. DOI: 10.1016/J.Biopsych.2018.02.126  0.51
2018 Trotti R, Parker D, Sabatinelli D, Tamminga C, Gershon E, Keedy S, Sweeney J, Keshavan M, Pearlson G, McDowell JE, Clementz BA. S188. Emotional processing in Bipolar Disorder With and Without Psychosis: Findings From the Psychosis and Affective Research Domains and Intermediate Phenotypes Consortium Biological Psychiatry. 83: S420. DOI: 10.1016/J.Biopsych.2018.02.1080  0.54
2017 Tamminga CA, Pearlson GD, Stan AD, Gibbons RD, Padmanabhan J, Keshavan M, Clementz BA. Strategies for Advancing Disease Definition Using Biomarkers and Genetics: The Bipolar and Schizophrenia Network for Intermediate Phenotypes. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. 2: 20-27. PMID 29560884 DOI: 10.1016/J.Bpsc.2016.07.005  0.579
2017 Scott D, Tamminga CA. Effects of genetic and environmental risk for schizophrenia on hippocampal activity and psychosis-like behavior in mice. Behavioural Brain Research. PMID 29155005 DOI: 10.1016/J.Bbr.2017.10.039  0.553
2017 Lencer R, Mills LJ, Alliey-Rodriguez N, Shafee R, Lee AM, Reilly JL, Sprenger A, McDowell JE, McCarroll SA, Keshavan MS, Pearlson GD, Tamminga CA, Clementz BA, Gershon ES, Sweeney JA, et al. Genome-wide association studies of smooth pursuit and antisaccade eye movements in psychotic disorders: findings from the B-SNIP study. Translational Psychiatry. 7: e1249. PMID 29064472 DOI: 10.1038/Tp.2017.210  0.565
2017 Gershon ES, Pearlson G, Keshavan MS, Tamminga C, Clementz B, Buckley PF, Alliey-Rodriguez N, Liu C, Sweeney JA, Keedy S, Meda SA, Tandon N, Shafee R, Bishop JR, Ivleva EI. Genetic analysis of deep phenotyping projects in common disorders. Schizophrenia Research. PMID 29056493 DOI: 10.1016/J.Schres.2017.09.031  0.537
2017 Hudgens-Haney ME, Ethridge LE, McDowell JE, Keedy SK, Pearlson GD, Tamminga CA, Keshavan MS, Sweeney JA, Clementz BA. Psychosis subgroups differ in intrinsic neural activity but not task-specific processing. Schizophrenia Research. PMID 28844436 DOI: 10.1016/J.Schres.2017.08.023  0.797
2017 Hochberger WC, Combs T, Reilly JL, Bishop JR, Keefe RSE, Clementz BA, Keshavan MS, Pearlson GD, Tamminga CA, Hill SK, Sweeney JA. Deviation from expected cognitive ability across psychotic disorders. Schizophrenia Research. PMID 28545944 DOI: 10.1016/J.Schres.2017.05.019  0.586
2017 Sheffield JM, Kandala S, Tamminga CA, Pearlson GD, Keshavan MS, Sweeney JA, Clementz BA, Lerman-Sinkoff DB, Hill SK, Barch DM. Transdiagnostic Associations Between Functional Brain Network Integrity and Cognition. Jama Psychiatry. PMID 28467520 DOI: 10.1001/Jamapsychiatry.2017.0669  0.537
2017 Hudgens-Haney ME, Ethridge LE, Knight JB, McDowell JE, Keedy SK, Pearlson GD, Tamminga CA, Keshavan MS, Sweeney JA, Clementz BA. Intrinsic neural activity differences among psychotic illnesses. Psychophysiology. PMID 28419491 DOI: 10.1111/Psyp.12875  0.816
2017 Eum S, Hill SK, Rubin LH, Carnahan RM, Reilly JL, Ivleva EI, Keedy SK, Tamminga CA, Pearlson GD, Clementz BA, Gershon ES, Keshavan MS, Keefe RS, Sweeney JA, Bishop JR. Cognitive burden of anticholinergic medications in psychotic disorders. Schizophrenia Research. PMID 28390849 DOI: 10.1016/J.Schres.2017.03.034  0.598
2017 Du Y, Pearlson GD, Lin D, Sui J, Chen J, Salman M, Tamminga CA, Ivleva EI, Sweeney JA, Keshavan MS, Clementz BA, Bustillo J, Calhoun VD. Identifying dynamic functional connectivity biomarkers using GIG-ICA: Application to schizophrenia, schizoaffective disorder, and psychotic bipolar disorder. Human Brain Mapping. PMID 28294459 DOI: 10.1002/Hbm.23553  0.622
2017 Rubin LH, Yao L, Keedy SK, Reilly JL, Bishop JR, Carter CS, Pournajafi-Nazarloo H, Drogos LL, Tamminga CA, Pearlson GD, Keshavan MS, Clementz BA, Hill SK, Liao W, Ji GJ, et al. Sex differences in associations of arginine vasopressin and oxytocin with resting-state functional brain connectivity. Journal of Neuroscience Research. 95: 576-586. PMID 27870395 DOI: 10.1002/Jnr.23820  0.522
2017 Francis A, Mothi S, Mathew I, Tandon N, Clementz B, Pearlson G, Sweeney J, Tamminga C, Keshavan M. SU83. Is the Anterior Splenium an Intermediate Phenotype Across the Psychosis Dimension? Schizophrenia Bulletin. 43: S191-S191. DOI: 10.1093/Schbul/Sbx024.079  0.468
2017 Hudgens-Haney ME, Hayrynen LK, Keshavan MS, Pearlson GD, Tamminga CA, Sweeney JA, Clementz BA. SU65. Neural Adaptation Differences Among Psychosis Biotypes Schizophrenia Bulletin. 43: S185-S185. DOI: 10.1093/Schbul/Sbx024.063  0.775
2017 Wojcik J, Lynda T, Lutz O, Mesholam-Gately R, Sweeney J, Pearlson G, Clementz B, Tamminga CA, Keshavan MS. SU49. Do Psychosis Biotypes Differ Across Traditional Schizophrenia Subtypes? Schizophrenia Bulletin. 43: S178-S179. DOI: 10.1093/Schbul/Sbx024.047  0.626
2017 Karpouzian T, Sweeney J, Rubin L, McDowell J, Clementz B, Gershon E, Keshavan M, Pearlson G, Tamminga C, Reilly J. SU25. Lack of Pupillary Modulation by Antisaccade Performance in Schizophrenia, Schizoaffective Disorder, and Psychotic Bipolar Disorder Suggests Reduced Top-Down Control During Response Preparation on an Executive Control Task Schizophrenia Bulletin. 43: S169-S170. DOI: 10.1093/Schbul/Sbx024.023  0.596
2017 Schneider Z, Parker D, Kittle F, McDowell J, Buckley P, Keedy S, Gershon E, Sweeney J, Keshavan M, Pearlson G, Tamminga C, Clementz B. SU5. Investigation of the Visual Steady-State Response in Schizophrenia, Schizoaffective, Psychotic, and Nonpsychotic Bipolar Disorders Schizophrenia Bulletin. 43: S162-S162. DOI: 10.1093/Schbul/Sbx024.004  0.59
2017 Okuneye V, Meda S, Keshavan MS, Sweeney J, Tamminga CA, Pearlson GD, Gershon E, Keedy SK. SA64. Hallucination Severity Predicted by Auditory Cortex Resting State Connectivity in Bipolar and Schizophrenia Network on Intermediate Phenotypes Study Schizophrenia Bulletin. 43: S136-S136. DOI: 10.1093/Schbul/Sbx023.063  0.406
2017 Bishop J, Hill S, Mills L, Alliey-Rodriguez N, Reilly J, Shaffee R, McCarroll S, Keefe R, Pearlson G, Clementz B, Tamminga C, Keshavan M, Gershon E, Sweeney J. M94. Genetic Analyses of Cognitive Performance in Psychotic Disorders From the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) Consortium Schizophrenia Bulletin. 43: S245-S245. DOI: 10.1093/Schbul/Sbx022.089  0.612
2017 Huang L, Sweeney JA, Hamm JP, Ethridge LE, Pearlson GD, Keshavan MS, Tamminga CA, Clementz BA. M61. Data-Driven Approach Identified Functionally and Physiologically Distinct Psychosis Subtypes Schizophrenia Bulletin. 43: S232-S233. DOI: 10.1093/Schbul/Sbx022.057  0.491
2017 Tandon N, Sudarshan M, Mothi S, Clementz BA, Pearlson GD, Sweeney J, Tamminga CA, Keshavan M. 205. Machine Learning to Further Improve Classification of Psychotic Disorders Using Clinical and Biological Stratification: Updates From the Bipolar Schizophrenia Network for Intermediate Phenotypes (BSNIP) Schizophrenia Bulletin. 43: S105-S105. DOI: 10.1093/Schbul/Sbx021.283  0.595
2017 Tamminga C. 114. What is New in the Treatment of Schizophrenia? Schizophrenia Bulletin. 43: S58-S58. DOI: 10.1093/Schbul/Sbx021.152  0.343
2017 Eum S, Hill SK, Carnahan RM, Reilly JL, Ivleva EI, Rubin LH, Keedy SK, Tamminga CA, Pearlson GD, Clementz BA, Gershon ES, Keefe RSE, Keshavan MS, Sweeney JA, Bishop JR. 68. Cognitive Burden of Anticholinergic Medications in Psychotic Disorders Schizophrenia Bulletin. 43. DOI: 10.1093/Schbul/Sbx021.107  0.532
2017 Sheffield J, Kandala S, Tamminga CA, Pearlson GD, Keshavan MS, Sweeney J, Clementz B, Hill SK, Leman-Sinkoff D, Barch D. 44. Transdiagnostic Relations Between Functional Brain Network Integrity and Cognition Schizophrenia Bulletin. 43: S24-S24. DOI: 10.1093/Schbul/Sbx021.063  0.521
2017 Lencer R, Mills LJ, Alliey-Rodriguez N, Reilly JL, Sprenger A, McDowell JE, Shafee R, McCarroll SA, Keshavan MS, Pearlson GD, Tamminga CA, Clementz BA, Gershon ES, Sweeney JA, Bishop JR. 11. Extended Association Studies of Smooth Pursuit and Antisaccade Eye Movements: Findings From the B-SNIP Study Schizophrenia Bulletin. 43: S10-S11. DOI: 10.1093/Schbul/Sbx021.030  0.407
2017 Ivleva E, Clementz B, Dutcher A, Aslan S, Witte B, Poudyal G, Lu H, Meda S, Pearlson GD, Sweeney J, Keshavan M, Tamminga C. 10. Brain Structure Biomarkers at the Psychosis/Nonpsychosis Interphase: Findings From the Bipolar–Schizophrenia Network for Intermediate Phenotypes Schizophrenia Bulletin. 43: S10-S10. DOI: 10.1093/Schbul/Sbx021.029  0.617
2017 Tamminga C, Clementz B, Keshavan M, Gershon E, Pearlson G, Ivleva E. 5.3 Endophenotypes Guide Psychosis Neurobiology Formulations Schizophrenia Bulletin. 43: S7-S7. DOI: 10.1093/Schbul/Sbx021.019  0.563
2017 Tamminga C, Ivleva E, Clementz B, Sweeney J, Pearlson G, Keshavan M. 3.2 Can Neurobiological Subgroups in Psychotic Illness Advantage Drug DISCOVERY? Schizophrenia Bulletin. 43: S3-S3. DOI: 10.1093/Schbul/Sbx021.008  0.629
2017 Pearlson G, Meda S, Khadka S, Tamminga C, Keshavan M, Clementz B, Sweeney J, Gershon E, Raskin S, Fallahi C. APPLYING MULTIVARIATE TECHNIQUES, INCLUDING PARALLEL ICA TO COMMON COMPLEX PSYCHIATRIC ENDOPHENOTYPES European Neuropsychopharmacology. 27: S519. DOI: 10.1016/J.Euroneuro.2016.09.636  0.55
2017 Lencer R, Mills LJ, Alliey-Rodriguez N, Reilly JL, Sprenger A, McDowell JE, Keshavan MS, Pearlson GD, McCarroll S, Tamminga CA, Clementz BA, Gershon ES, Sweeney JA, Bishop JR. Genome-Wide Association Studies Of Smooth Pursuit Eye Movements Across Psychotic Disorders: Preliminary Findings From The B-Snip Sample European Neuropsychopharmacology. 27. DOI: 10.1016/J.Euroneuro.2016.09.580  0.615
2017 Alliey N, Grey TA, Shafee R, Padmanabhan J, Tandon N, Gage D, McCarroll S, Bishop JR, Keshavan MS, Buckley P, Pearlson G, Tamminga C, Sweeney J, Keedy S, Gershon E. Gwas Of Bsnip Biofactors And Biotypes As Intermediate Phenotypes For Psychosis European Neuropsychopharmacology. 27: S439-S440. DOI: 10.1016/J.Euroneuro.2016.09.501  0.309
2017 Khadka S, Tamminga C, Keshavan M, Clementz B, Gershon E, Pearlson GD. 822. Abnormal Resting State Functional Connectivity in Bipolar Disorder with and without Psychosis Biological Psychiatry. 81: S333-S334. DOI: 10.1016/J.Biopsych.2017.02.889  0.572
2017 Lutz O, Lizano P, Mothi SS, Tandon N, Tamminga C, Clementz B, Sweeney J, Pearlson G, Keshavan M. 965. Investigating Brain Structure Across Bipolar Disorder Subtypes: Findings from the Psychosis Affective Research Domain Intermediate Phenotypes (PARDIP) Study Biological Psychiatry. 81. DOI: 10.1016/J.Biopsych.2017.02.691  0.561
2017 Bobilev A, Li W, Clementz BA, Keshavan M, Pearlson G, Sweeney J, Tamminga C. 850. Identification of Biotypes in Psychosis using Biomarkers and iPSCs Biological Psychiatry. 81: S344. DOI: 10.1016/J.Biopsych.2017.02.575  0.521
2017 Scott D, Tamminga CA. 842. Changes in Hippocampal Subfield Activity Contribute to Psychosis-Like Behaviors in Mice Biological Psychiatry. 81: S341. DOI: 10.1016/J.Biopsych.2017.02.567  0.443
2017 Ghose S, Mukherjee S, Pawar S, Durakoglugil D, Gleason K, Tamminga C, Hwang TH. 572. Cannabis Use and Matrix Metalloproteases in Schizophrenia Biological Psychiatry. 81. DOI: 10.1016/J.Biopsych.2017.02.442  0.377
2017 Massa N, Bhattacharya A, Sweeney JA, Pearlson GD, Keshavan MS, Tamminga CA, Clementz BA, Duncan E. 62. Acoustic Startle Latency is Prolonged in Schizophrenia in the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) Cohort Biological Psychiatry. 81: S26. DOI: 10.1016/J.Biopsych.2017.02.073  0.616
2016 Meda SA, Clementz BA, Sweeney JA, Keshavan MS, Tamminga CA, Ivleva EI, Pearlson GD. Examining Functional Resting-State Connectivity in Psychosis and Its Subgroups in the Bipolar-Schizophrenia Network on Intermediate Phenotypes Cohort. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. 1: 488-497. PMID 29653095 DOI: 10.1016/J.Bpsc.2016.07.001  0.608
2016 Braff DL, Tamminga CA. Endophenotypes, Epigenetics, Polygenicity and More: Irv Gottesman's Dynamic Legacy. Schizophrenia Bulletin. PMID 27872267 DOI: 10.1093/Schbul/Sbw157  0.452
2016 Ivleva EI, Clementz BA, Dutcher AM, Arnold SJ, Jeon-Slaughter H, Aslan S, Witte B, Poudyal G, Lu H, Meda SA, Pearlson GD, Sweeney JA, Keshavan MS, Tamminga CA. Brain Structure Biomarkers in the Psychosis Biotypes: Findings From the Bipolar-Schizophrenia Network for Intermediate Phenotypes. Biological Psychiatry. PMID 27817844 DOI: 10.1016/J.Biopsych.2016.08.030  0.611
2016 Hager B, Yang AC, Brady R, Meda S, Clementz B, Pearlson GD, Sweeney JA, Tamminga C, Keshavan M. Neural complexity as a potential translational biomarker for psychosis. Journal of Affective Disorders. PMID 27814962 DOI: 10.1016/J.Jad.2016.10.016  0.556
2016 Tandon N, Nanda P, Padmanabhan JL, Mathew IT, Eack SM, Narayanan B, Meda SA, Bergen SE, Ruaño G, Windemuth A, Kocherla M, Petryshen TL, Clementz B, Sweeney J, Tamminga C, et al. Novel gene-brain structure relationships in psychotic disorder revealed using parallel independent component analyses. Schizophrenia Research. PMID 27789186 DOI: 10.1016/J.Schres.2016.10.026  0.626
2016 Reilly JL, Hill SK, Gold JM, Keefe RS, Clementz BA, Gershon E, Keshavan MS, Pearlson G, Tamminga CA, Sweeney JA. Impaired Context Processing is Attributable to Global Neuropsychological Impairment in Schizophrenia and Psychotic Bipolar Disorder. Schizophrenia Bulletin. PMID 27306316 DOI: 10.1093/Schbul/Sbw081  0.617
2016 Pearlson GD, Clementz BA, Sweeney JA, Keshavan MS, Tamminga CA. Does Biology Transcend the Symptom-based Boundaries of Psychosis? The Psychiatric Clinics of North America. 39: 165-74. PMID 27216897 DOI: 10.1016/J.Psc.2016.01.001  0.553
2016 Hanna RC, Shalvoy A, Cullum CM, Ivleva EI, Keshavan M, Pearlson G, Hill SK, Sweeney JA, Tamminga CA, Ghose S. Cognitive Function in Individuals With Psychosis: Moderation by Adolescent Cannabis Use. Schizophrenia Bulletin. PMID 27033329 DOI: 10.1093/Schbul/Sbw030  0.415
2016 Shukla AA, Jha M, Birchfield T, Mukherjee S, Gleason K, Abdisalaam S, Asaithamby A, Adams-Huet B, Tamminga CA, Ghose S. COMT val158met polymorphism and molecular alterations in the human dorsolateral prefrontal cortex: Differences in controls and in schizophrenia. Schizophrenia Research. PMID 27021555 DOI: 10.1016/J.Schres.2016.03.019  0.39
2016 Padmanabhan JL, Nanda P, Tandon N, Mothi SS, Bolo N, McCarroll S, Clementz BA, Gershon ES, Pearlson GD, Sweeney JA, Tamminga CA, Keshavan MS. Polygenic risk for type 2 diabetes mellitus among individuals with psychosis and their relatives. Journal of Psychiatric Research. 77: 52-58. PMID 26978185 DOI: 10.1016/J.Jpsychires.2016.02.015  0.491
2016 Rubin LH, Connelly JJ, Reilly JL, Carter CS, Drogos LL, Pournajafi-Nazarloo H, Ruocco AC, Keedy SK, Matthew I, Tandon N, Pearlson GD, Clementz BA, Tamminga CA, Gershon ES, Keshavan MS, et al. Sex and diagnosis specific associations between DNA methylation of the oxytocin receptor gene with emotion processing and temporal-limbic and prefrontal brain volumes in psychotic disorders. Biological Psychiatry : Cognitive Neuroscience and Neuroimaging. 1: 141-151. PMID 26977453 DOI: 10.1016/J.Bpsc.2015.10.003  0.546
2016 Francis AN, Mothi SS, Mathew IT, Tandon N, Clementz B, Pearlson GD, Sweeney JA, Tamminga CA, Keshavan MS. Callosal Abnormalities Across the Psychosis Dimension: Bipolar Schizophrenia Network on Intermediate Phenotypes. Biological Psychiatry. PMID 26954565 DOI: 10.1016/J.Biopsych.2015.12.026  0.641
2015 Wang Z, Meda SA, Keshavan MS, Tamminga CA, Sweeney JA, Clementz BA, Schretlen DJ, Calhoun VD, Lui S, Pearlson GD. Large-Scale Fusion of Gray Matter and Resting-State Functional MRI Reveals Common and Distinct Biological Markers across the Psychosis Spectrum in the B-SNIP Cohort. Frontiers in Psychiatry. 6: 174. PMID 26732139 DOI: 10.3389/Fpsyt.2015.00174  0.625
2015 Nanda P, Tandon N, Mathew IT, Padmanabhan JL, Clementz BA, Pearlson GD, Sweeney JA, Tamminga CA, Keshavan MS. Impulsivity across the psychosis spectrum: Correlates of cortical volume, suicidal history, and social and global function. Schizophrenia Research. PMID 26711526 DOI: 10.1016/J.Schres.2015.11.030  0.596
2015 Clementz BA, Sweeney JA, Hamm JP, Ivleva EI, Ethridge LE, Pearlson GD, Keshavan MS, Tamminga CA. Identification of Distinct Psychosis Biotypes Using Brain-Based Biomarkers. The American Journal of Psychiatry. appiajp201514091200. PMID 26651391 DOI: 10.1176/Appi.Ajp.2015.14091200  0.539
2015 Hochberger WC, Hill SK, Nelson CL, Reilly JL, Keefe RS, Pearlson GD, Keshavan MS, Tamminga CA, Clementz BA, Sweeney JA. Unitary construct of generalized cognitive ability underlying BACS performance across psychotic disorders and in their first-degree relatives. Schizophrenia Research. PMID 26645510 DOI: 10.1016/J.Schres.2015.11.022  0.617
2015 Soh P, Narayanan B, Khadka S, Calhoun VD, Keshavan MS, Tamminga CA, Sweeney JA, Clementz BA, Pearlson GD. Joint Coupling of Awake EEG Frequency Activity and MRI Gray Matter Volumes in the Psychosis Dimension: A BSNIP Study. Frontiers in Psychiatry. 6: 162. PMID 26617533 DOI: 10.3389/Fpsyt.2015.00162  0.601
2015 Lencer R, Sprenger A, Reilly JL, McDowell JE, Rubin LH, Badner JA, Keshavan MS, Pearlson GD, Tamminga CA, Gershon ES, Clementz BA, Sweeney JA. Pursuit eye movements as an intermediate phenotype across psychotic disorders: Evidence from the B-SNIP study. Schizophrenia Research. PMID 26481615 DOI: 10.1016/J.Schres.2015.09.032  0.62
2015 Mokhtari M, Narayanan B, Hamm JP, Soh P, Calhoun VD, Ruaño G, Kocherla M, Windemuth A, Clementz BA, Tamminga CA, Sweeney JA, Keshavan MS, Pearlson GD. Multivariate Genetic Correlates of the Auditory Paired Stimuli-Based P2 Event-Related Potential in the Psychosis Dimension From the BSNIP Study. Schizophrenia Bulletin. PMID 26462502 DOI: 10.1093/Schbul/Sbv147  0.562
2015 Lieberman JA, Davis RE, Correll CU, Goff DC, Kane JM, Tamminga CA, Mates S, Vanover KE. ITI-007 for the Treatment of Schizophrenia: A 4-Week Randomized, Double-Blind, Controlled Trial. Biological Psychiatry. PMID 26444072 DOI: 10.1016/J.Biopsych.2015.08.026  0.382
2015 Tamminga CA, Zukin RS. Schizophrenia: Evidence implicating hippocampal GluN2B protein and REST epigenetics in psychosis pathophysiology. Neuroscience. PMID 26211447 DOI: 10.1016/J.Neuroscience.2015.07.038  0.343
2015 Samudra N, Ivleva EI, Hubbard NA, Rypma B, Sweeney JA, Clementz BA, Keshavan MS, Pearlson GD, Tamminga CA. Alterations in hippocampal connectivity across the psychosis dimension. Psychiatry Research. 233: 148-57. PMID 26123450 DOI: 10.1016/J.Pscychresns.2015.06.004  0.599
2015 Narayanan B, Soh P, Calhoun VD, Ruaño G, Kocherla M, Windemuth A, Clementz BA, Tamminga CA, Sweeney JA, Keshavan MS, Pearlson GD. Multivariate genetic determinants of EEG oscillations in schizophrenia and psychotic bipolar disorder from the BSNIP study. Translational Psychiatry. 5: e588. PMID 26101851 DOI: 10.1038/Tp.2015.76  0.607
2015 Meda SA, Wang Z, Ivleva EI, Poudyal G, Keshavan MS, Tamminga CA, Sweeney JA, Clementz BA, Schretlen DJ, Calhoun VD, Lui S, Damaraju E, Pearlson GD. Frequency-Specific Neural Signatures of Spontaneous Low-Frequency Resting State Fluctuations in Psychosis: Evidence From Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) Consortium. Schizophrenia Bulletin. 41: 1336-48. PMID 26012519 DOI: 10.1093/Schbul/Sbv064  0.594
2015 Kristian Hill S, Buchholz A, Amsbaugh H, Reilly JL, Rubin LH, Gold JM, Keefe RS, Pearlson GD, Keshavan MS, Tamminga CA, Sweeney JA. Working memory impairment in probands with schizoaffective disorder and first degree relatives of schizophrenia probands extend beyond deficits predicted by generalized neuropsychological impairment. Schizophrenia Research. 166: 310-5. PMID 26008884 DOI: 10.1016/J.Schres.2015.05.018  0.387
2015 Mothi SS, Tandon N, Padmanabhan J, Mathew IT, Clementz B, Tamminga C, Pearlson G, Sweeney J, Keshavan MS. Increased cardiometabolic dysfunction in first-degree relatives of patients with psychotic disorders. Schizophrenia Research. 165: 103-7. PMID 25900543 DOI: 10.1016/J.Schres.2015.03.034  0.595
2015 Pinkham AE, Liu P, Lu H, Kriegsman M, Simpson C, Tamminga C. Amygdala Hyperactivity at Rest in Paranoid Individuals With Schizophrenia. The American Journal of Psychiatry. appiajp201414081000. PMID 25815418 DOI: 10.1176/Appi.Ajp.2014.14081000  0.417
2015 Narayanan B, Ethridge LE, O'Neil K, Dunn S, Mathew I, Tandon N, Calhoun VD, Ruaño G, Kocherla M, Windemuth A, Clementz BA, Tamminga CA, Sweeney JA, Keshavan MS, Pearlson GD. Genetic Sources of Subcomponents of Event-Related Potential in the Dimension of Psychosis Analyzed From the B-SNIP Study. The American Journal of Psychiatry. 172: 466-78. PMID 25615564 DOI: 10.1176/Appi.Ajp.2014.13101411  0.587
2015 Li W, Ghose S, Gleason K, Begovic A, Perez J, Bartko J, Russo S, Wagner AD, Selemon L, Tamminga CA. Synaptic proteins in the hippocampus indicative of increased neuronal activity in CA3 in schizophrenia. The American Journal of Psychiatry. 172: 373-82. PMID 25585032 DOI: 10.1176/Appi.Ajp.2014.14010123  0.357
2015 Giakoumatos CI, Nanda P, Mathew IT, Tandon N, Shah J, Bishop JR, Clementz BA, Pearlson GD, Sweeney JA, Tamminga CA, Keshavan MS. Effects of lithium on cortical thickness and hippocampal subfield volumes in psychotic bipolar disorder. Journal of Psychiatric Research. 61: 180-7. PMID 25563516 DOI: 10.1016/J.Jpsychires.2014.12.008  0.552
2015 Clementz BA, Sweeney J, Keshavan MS, Pearlson G, Tamminga CA. Using biomarker batteries. Biological Psychiatry. 77: 90-2. PMID 25524306 DOI: 10.1016/J.Biopsych.2014.10.012  0.591
2015 Hill SK, Reilly JL, Ragozzino ME, Rubin LH, Bishop JR, Gur RC, Gershon ES, Tamminga CA, Pearlson GD, Keshavan MS, Keefe RS, Sweeney JA. Regressing to Prior Response Preference After Set Switching Implicates Striatal Dysfunction Across Psychotic Disorders: Findings From the B-SNIP Study. Schizophrenia Bulletin. 41: 940-50. PMID 25194139 DOI: 10.1093/Schbul/Sbu130  0.415
2015 Lui S, Yao L, Xiao Y, Keedy SK, Reilly JL, Keefe RS, Tamminga CA, Keshavan MS, Pearlson GD, Gong Q, Sweeney JA. Resting-state brain function in schizophrenia and psychotic bipolar probands and their first-degree relatives. Psychological Medicine. 45: 97-108. PMID 25066779 DOI: 10.1017/S003329171400110X  0.465
2015 Ethridge LE, Hamm JP, Pearlson GD, Tamminga CA, Sweeney JA, Keshavan MS, Clementz BA. Event-related potential and time-frequency endophenotypes for schizophrenia and psychotic bipolar disorder. Biological Psychiatry. 77: 127-36. PMID 24923619 DOI: 10.1016/J.Biopsych.2014.03.032  0.603
2015 Stan AD, Ghose S, Zhao C, Hulsey K, Mihalakos P, Yanagi M, Morris SU, Bartko JJ, Choi C, Tamminga CA. Magnetic resonance spectroscopy and tissue protein concentrations together suggest lower glutamate signaling in dentate gyrus in schizophrenia. Molecular Psychiatry. 20: 433-9. PMID 24912493 DOI: 10.1038/Mp.2014.54  0.391
2015 Padmanabhan JL, Tandon N, Haller CS, Mathew IT, Eack SM, Clementz BA, Pearlson GD, Sweeney JA, Tamminga CA, Keshavan MS. Correlations between brain structure and symptom dimensions of psychosis in schizophrenia, schizoaffective, and psychotic bipolar I disorders. Schizophrenia Bulletin. 41: 154-62. PMID 24907239 DOI: 10.1093/Schbul/Sbu075  0.595
2015 Arnold SJ, Ivleva EI, Gopal TA, Reddy AP, Jeon-Slaughter H, Sacco CB, Francis AN, Tandon N, Bidesi AS, Witte B, Poudyal G, Pearlson GD, Sweeney JA, Clementz BA, Keshavan MS, ... Tamminga CA, et al. Hippocampal volume is reduced in schizophrenia and schizoaffective disorder but not in psychotic bipolar I disorder demonstrated by both manual tracing and automated parcellation (FreeSurfer). Schizophrenia Bulletin. 41: 233-49. PMID 24557771 DOI: 10.1093/Schbul/Sbu009  0.605
2015 Samudra N, Ivleva EI, Hubbard NA, Rypma B, Sweeney JA, Clementz BA, Keshavan MS, Pearlson GD, Tamminga CA. Alterations in hippocampal connectivity across the psychosis dimension Psychiatry Research - Neuroimaging. 233: 148-157. DOI: 10.1016/j.pscychresns.2015.06.004  0.486
2014 Ethridge LE, Soilleux M, Nakonezny PA, Reilly JL, Hill SK, Keefe RS, Gershon ES, Pearlson GD, Tamminga CA, Keshavan MS, Sweeney JA. Behavioral response inhibition in psychotic disorders: diagnostic specificity, familiality and relation to generalized cognitive deficit. Schizophrenia Research. 159: 491-8. PMID 25261042 DOI: 10.1016/J.Schres.2014.08.025  0.436
2014 Krawczyk DC, Kandalaft MR, Didehbani N, Allen TT, McClelland MM, Tamminga CA, Chapman SB. An investigation of reasoning by analogy in schizophrenia and autism spectrum disorder. Frontiers in Human Neuroscience. 8: 517. PMID 25191240 DOI: 10.3389/Fnhum.2014.00517  0.349
2014 Das T, Ivleva EI, Wagner AD, Stark CE, Tamminga CA. Loss of pattern separation performance in schizophrenia suggests dentate gyrus dysfunction. Schizophrenia Research. 159: 193-7. PMID 25176349 DOI: 10.1016/J.Schres.2014.05.006  0.371
2014 Ruocco AC, Reilly JL, Rubin LH, Daros AR, Gershon ES, Tamminga CA, Pearlson GD, Hill SK, Keshavan MS, Gur RC, Sweeney JA. Emotion recognition deficits in schizophrenia-spectrum disorders and psychotic bipolar disorder: Findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) study. Schizophrenia Research. 158: 105-12. PMID 25052782 DOI: 10.1016/J.Schres.2014.07.001  0.444
2014 Mathew I, Gardin TM, Tandon N, Eack S, Francis AN, Seidman LJ, Clementz B, Pearlson GD, Sweeney JA, Tamminga CA, Keshavan MS. Medial temporal lobe structures and hippocampal subfields in psychotic disorders: findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) study. Jama Psychiatry. 71: 769-77. PMID 24828364 DOI: 10.1001/Jamapsychiatry.2014.453  0.637
2014 Meda SA, Ruaño G, Windemuth A, O'Neil K, Berwise C, Dunn SM, Boccaccio LE, Narayanan B, Kocherla M, Sprooten E, Keshavan MS, Tamminga CA, Sweeney JA, Clementz BA, Calhoun VD, et al. Multivariate analysis reveals genetic associations of the resting default mode network in psychotic bipolar disorder and schizophrenia. Proceedings of the National Academy of Sciences of the United States of America. 111: E2066-75. PMID 24778245 DOI: 10.1073/Pnas.1313093111  0.621
2014 Hamm JP, Ethridge LE, Boutros NN, Keshavan MS, Sweeney JA, Pearlson GD, Tamminga CA, Clementz BA. Diagnostic specificity and familiality of early versus late evoked potentials to auditory paired stimuli across the schizophrenia-bipolar psychosis spectrum. Psychophysiology. 51: 348-57. PMID 24660885 DOI: 10.1111/Psyp.12185  0.605
2014 Rubin LH, Carter CS, Bishop JR, Pournajafi-Nazarloo H, Drogos LL, Hill SK, Ruocco AC, Keedy SK, Reilly JL, Keshavan MS, Pearlson GD, Tamminga CA, Gershon ES, Sweeney JA. Reduced levels of vasopressin and reduced behavioral modulation of oxytocin in psychotic disorders. Schizophrenia Bulletin. 40: 1374-84. PMID 24619535 DOI: 10.1093/Schbul/Sbu027  0.432
2014 Tamminga CA, Pearlson G, Keshavan M, Sweeney J, Clementz B, Thaker G. Bipolar and schizophrenia network for intermediate phenotypes: outcomes across the psychosis continuum. Schizophrenia Bulletin. 40: S131-7. PMID 24562492 DOI: 10.1093/Schbul/Sbt179  0.636
2014 Gonzalez R, Tamminga CA, Tohen M, Suppes T. The relationship between affective state and the rhythmicity of activity in bipolar disorder. The Journal of Clinical Psychiatry. 75: e317-22. PMID 24500063 DOI: 10.4088/Jcp.13M08506  0.339
2014 Tamminga CA. Approaching human neuroscience for disease understanding. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 13: 41-3. PMID 24497244 DOI: 10.1002/Wps.20099  0.376
2014 Narayanan B, O'Neil K, Berwise C, Stevens MC, Calhoun VD, Clementz BA, Tamminga CA, Sweeney JA, Keshavan MS, Pearlson GD. Resting state electroencephalogram oscillatory abnormalities in schizophrenia and psychotic bipolar patients and their relatives from the bipolar and schizophrenia network on intermediate phenotypes study. Biological Psychiatry. 76: 456-65. PMID 24439302 DOI: 10.1016/J.Biopsych.2013.12.008  0.637
2014 Nanda P, Tandon N, Mathew IT, Giakoumatos CI, Abhishekh HA, Clementz BA, Pearlson GD, Sweeney J, Tamminga CA, Keshavan MS. Local gyrification index in probands with psychotic disorders and their first-degree relatives. Biological Psychiatry. 76: 447-55. PMID 24369266 DOI: 10.1016/J.Biopsych.2013.11.018  0.607
2014 Reilly JL, Frankovich K, Hill S, Gershon ES, Keefe RS, Keshavan MS, Pearlson GD, Tamminga CA, Sweeney JA. Elevated antisaccade error rate as an intermediate phenotype for psychosis across diagnostic categories. Schizophrenia Bulletin. 40: 1011-21. PMID 24080895 DOI: 10.1093/Schbul/Sbt132  0.389
2014 Dietz DM, Kennedy PJ, Sun H, Maze I, Gancarz AM, Vialou V, Koo JW, Mouzon E, Ghose S, Tamminga CA, Nestler EJ. ΔFosB induction in prefrontal cortex by antipsychotic drugs is associated with negative behavioral outcomes. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 538-44. PMID 24067299 DOI: 10.1038/Npp.2013.255  0.388
2014 Rosenfeld ES, Pearlson GD, Sweeney JA, Tamminga CA, Keshavan MS, Nonterah C, Stevens MC. Prolonged hemodynamic response during incidental facial emotion processing in inter-episode bipolar I disorder. Brain Imaging and Behavior. 8: 73-86. PMID 23975275 DOI: 10.1007/S11682-013-9246-Z  0.357
2014 Unschuld PG, Buchholz AS, Varvaris M, van Zijl PC, Ross CA, Pekar JJ, Hock C, Sweeney JA, Tamminga CA, Keshavan MS, Pearlson GD, Thaker GK, Schretlen DJ. Prefrontal brain network connectivity indicates degree of both schizophrenia risk and cognitive dysfunction. Schizophrenia Bulletin. 40: 653-64. PMID 23778975 DOI: 10.1093/schbul/sbt077  0.426
2014 Yanagi M, Joho RH, Southcott SA, Shukla AA, Ghose S, Tamminga CA. Kv3.1-containing K(+) channels are reduced in untreated schizophrenia and normalized with antipsychotic drugs. Molecular Psychiatry. 19: 573-9. PMID 23628987 DOI: 10.1038/Mp.2013.49  0.323
2014 Ivleva EI, Moates AF, Hamm JP, Bernstein IH, O'Neill HB, Cole D, Clementz BA, Thaker GK, Tamminga CA. Smooth pursuit eye movement, prepulse inhibition, and auditory paired stimuli processing endophenotypes across the schizophrenia-bipolar disorder psychosis dimension. Schizophrenia Bulletin. 40: 642-52. PMID 23599252 DOI: 10.1093/Schbul/Sbt047  0.593
2014 Padmanabhan J, Tandon N, Haller C, Mathew I, Ruano G, Windemuth A, Clementz B, Sweeney J, Pearlson GD, Tamminga C, Keshavan M. Poster #S141 ASSOCIATIONS BETWEEN POLYGENIC RISK SCORES FOR TYPE 2 DIABETES MELLITUS AND CO-MORBID DIABETES IN A SAMPLE OF SUBJECTS WITH SCHIZOPHRENIA, SCHIZOAFFECTIVE, OR BIPOLAR I DISORDERS Schizophrenia Research. 153. DOI: 10.1016/S0920-9964(14)70420-7  0.546
2014 Pearlson GD, Tamminga C, Keshavan M, Thaker G, Clementz B, Sweeney J, Meda S, Khadka S. STRUCTURAL AND FUNCTIONAL NEUROIMAGING FINDINGS IN THE BSNIP PSYCHOSIS CONSORTIUM Schizophrenia Research. 153: S13-S14. DOI: 10.1016/S0920-9964(14)70041-6  0.515
2013 Ivleva EI, Bidesi AS, Keshavan MS, Pearlson GD, Meda SA, Dodig D, Moates AF, Lu H, Francis AN, Tandon N, Schretlen DJ, Sweeney JA, Clementz BA, Tamminga CA. Gray matter volume as an intermediate phenotype for psychosis: Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP). The American Journal of Psychiatry. 170: 1285-96. PMID 24185241 DOI: 10.1176/Appi.Ajp.2013.13010126  0.637
2013 Hamm JP, Ethridge LE, Shapiro JR, Pearlson GD, Tamminga CA, Sweeney JA, Keshavan MS, Thaker GK, Clementz BA. Family history of psychosis moderates early auditory cortical response abnormalities in non-psychotic bipolar disorder. Bipolar Disorders. 15: 774-86. PMID 23941660 DOI: 10.1111/Bdi.12110  0.607
2013 Giakoumatos CI, Tandon N, Shah J, Mathew IT, Brady RO, Clementz BA, Pearlson GD, Thaker GK, Tamminga CA, Sweeney JA, Keshavan MS. Are structural brain abnormalities associated with suicidal behavior in patients with psychotic disorders? Journal of Psychiatric Research. 47: 1389-95. PMID 23866739 DOI: 10.1016/J.Jpsychires.2013.06.011  0.577
2013 Tamminga CA, Ivleva EI, Keshavan MS, Pearlson GD, Clementz BA, Witte B, Morris DW, Bishop J, Thaker GK, Sweeney JA. Clinical phenotypes of psychosis in the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP). The American Journal of Psychiatry. 170: 1263-74. PMID 23846857 DOI: 10.1176/Appi.Ajp.2013.12101339  0.635
2013 Skudlarski P, Schretlen DJ, Thaker GK, Stevens MC, Keshavan MS, Sweeney JA, Tamminga CA, Clementz BA, O'Neil K, Pearlson GD. Diffusion tensor imaging white matter endophenotypes in patients with schizophrenia or psychotic bipolar disorder and their relatives. The American Journal of Psychiatry. 170: 886-98. PMID 23771210 DOI: 10.1176/Appi.Ajp.2013.12111448  0.639
2013 Hill SK, Reilly JL, Keefe RS, Gold JM, Bishop JR, Gershon ES, Tamminga CA, Pearlson GD, Keshavan MS, Sweeney JA. Neuropsychological impairments in schizophrenia and psychotic bipolar disorder: findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) study. The American Journal of Psychiatry. 170: 1275-84. PMID 23771174 DOI: 10.1176/Appi.Ajp.2013.12101298  0.456
2013 Khadka S, Meda SA, Stevens MC, Glahn DC, Calhoun VD, Sweeney JA, Tamminga CA, Keshavan MS, O'Neil K, Schretlen D, Pearlson GD. Is aberrant functional connectivity a psychosis endophenotype? A resting state functional magnetic resonance imaging study. Biological Psychiatry. 74: 458-66. PMID 23746539 DOI: 10.1016/J.Biopsych.2013.04.024  0.421
2013 Keshavan MS, Clementz BA, Pearlson GD, Sweeney JA, Tamminga CA. Reimagining psychoses: an agnostic approach to diagnosis. Schizophrenia Research. 146: 10-6. PMID 23498153 DOI: 10.1016/J.Schres.2013.02.022  0.54
2013 Tamminga CA. Psychosis is emerging as a learning and memory disorder. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 38: 247. PMID 23147488 DOI: 10.1038/Npp.2012.187  0.31
2013 Alaräisänen A, Kukkohovi L, Rönkkö E, Kyllönen M, Miettunen J, Isohanni M, Veijola J, Tamminga C. 1637 – Recall of previously learned associations and memory generalization in schizophrenia, other psychoses, siblings, and controls. The northern finland 1966 birth cohort study European Psychiatry. 28: 1. DOI: 10.1016/S0924-9338(13)76628-8  0.389
2012 Ivleva EI, Bidesi AS, Thomas BP, Meda SA, Francis A, Moates AF, Witte B, Keshavan MS, Tamminga CA. Brain gray matter phenotypes across the psychosis dimension. Psychiatry Research. 204: 13-24. PMID 23177922 DOI: 10.1016/J.Pscychresns.2012.05.001  0.431
2012 Didehbani N, Shad MU, Tamminga CA, Kandalaft MR, Allen TT, Chapman SB, Krawczyk DC. Insight and empathy in schizophrenia. Schizophrenia Research. 142: 246-7. PMID 23043874 DOI: 10.1016/J.Schres.2012.09.010  0.418
2012 Ethridge LE, Hamm JP, Shapiro JR, Summerfelt AT, Keedy SK, Stevens MC, Pearlson G, Tamminga CA, Boutros NN, Sweeney JA, Keshavan MS, Thaker G, Clementz BA. Neural activations during auditory oddball processing discriminating schizophrenia and psychotic bipolar disorder. Biological Psychiatry. 72: 766-74. PMID 22572033 DOI: 10.1016/J.Biopsych.2012.03.034  0.588
2012 Moates AF, Ivleva EI, O'Neill HB, Krishna N, Cullum CM, Thaker GK, Tamminga CA. Predictive pursuit association with deficits in working memory in psychosis. Biological Psychiatry. 72: 752-7. PMID 22554452 DOI: 10.1016/J.Biopsych.2012.03.030  0.389
2012 Ivleva EI, Shohamy D, Mihalakos P, Morris DW, Carmody T, Tamminga CA. Memory generalization is selectively altered in the psychosis dimension. Schizophrenia Research. 138: 74-80. PMID 22551681 DOI: 10.1016/J.Schres.2012.04.004  0.349
2012 Tamminga CA, Southcott S, Sacco C, Wagner AD, Ghose S. Glutamate dysfunction in hippocampus: relevance of dentate gyrus and CA3 signaling. Schizophrenia Bulletin. 38: 927-35. PMID 22532703 DOI: 10.1093/Schbul/Sbs062  0.335
2012 Didehbani N, Shad MU, Kandalaft MR, Allen TT, Tamminga CA, Krawczyk DC, Chapman SB. Brief report: Insight into illness and social attributional style in Asperger's syndrome. Journal of Autism and Developmental Disorders. 42: 2754-60. PMID 22527705 DOI: 10.1007/S10803-012-1532-X  0.312
2012 Shad MU, Keshavan MS, Steinberg JL, Mihalakos P, Thomas BP, Motes MA, Soares JC, Tamminga CA. Neurobiology of self-awareness in schizophrenia: an fMRI study. Schizophrenia Research. 138: 113-9. PMID 22480958 DOI: 10.1016/J.Schres.2012.03.016  0.391
2012 Tamminga CA, Thomas BP, Chin R, Mihalakos P, Youens K, Wagner AD, Preston AR. Hippocampal novelty activations in schizophrenia: disease and medication effects. Schizophrenia Research. 138: 157-63. PMID 22480957 DOI: 10.1016/J.Schres.2012.03.019  0.415
2012 Meda SA, Gill A, Stevens MC, Lorenzoni RP, Glahn DC, Calhoun VD, Sweeney JA, Tamminga CA, Keshavan MS, Thaker G, Pearlson GD. Differences in resting-state functional magnetic resonance imaging functional network connectivity between schizophrenia and psychotic bipolar probands and their unaffected first-degree relatives. Biological Psychiatry. 71: 881-9. PMID 22401986 DOI: 10.1016/J.Biopsych.2012.01.025  0.449
2012 Ivleva EI, Morris DW, Osuji J, Moates AF, Carmody TJ, Thaker GK, Cullum M, Tamminga CA. Cognitive endophenotypes of psychosis within dimension and diagnosis. Psychiatry Research. 196: 38-44. PMID 22342122 DOI: 10.1016/J.Psychres.2011.08.021  0.46
2012 Ibrahim HM, Tamminga CA. Treating Impaired Cognition in Schizophrenia Current Pharmaceutical Biotechnology. 13: 1587-1594. PMID 22283754 DOI: 10.2174/138920112800784772  0.421
2012 Hamm JP, Ethridge LE, Shapiro JR, Stevens MC, Boutros NN, Summerfelt AT, Keshavan MS, Sweeney JA, Pearlson G, Tamminga CA, Thaker G, Clementz BA. Spatiotemporal and frequency domain analysis of auditory paired stimuli processing in schizophrenia and bipolar disorder with psychosis. Psychophysiology. 49: 522-30. PMID 22176721 DOI: 10.1111/J.1469-8986.2011.01327.X  0.589
2012 Yanagi M, Southcott S, Lister J, Tamminga CA. Animal models of schizophrenia emphasizing construct validity. Progress in Molecular Biology and Translational Science. 105: 411-44. PMID 22137438 DOI: 10.1016/B978-0-12-394596-9.00012-3  0.412
2012 Tamminga CA, Medoff DR. Studies in schizophrenia: pathophysiology and treatment. Dialogues in Clinical Neuroscience. 4: 432-7. PMID 22033751  0.337
2012 Bobb DS, Adinoff B, Laken SJ, McClintock SM, Rubia K, Huang HW, Husain MM, Mapes KS, Tamminga C, Cullum CM, Gopinath K, Trivedi MH, Kozel FA. Neural correlates of successful response inhibition in unmedicated patients with late-life depression. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 20: 1057-69. PMID 21997605 DOI: 10.1097/Jgp.0B013E318235B728  0.316
2012 Ethridge LE, Hamm JP, Shapiro JR, Summerfelt AT, Keedy SK, Stevens MC, Pearlson G, Tamminga CA, Boutros NN, Sweeney JA, Keshavan MS, Thaker G, Clementz BA. Late beta accentuation and decreased N2 amplitude to auditory oddball stimuli discriminate psychosis groups and co-occur in first-degree relatives F1000research. 3. DOI: 10.7490/F1000Research.1090558.1  0.477
2012 Hamm JP, Ethridge LE, Shapiro JR, Parker EM, Keshavan MS, Sweeney JA, Pearlson G, Tamminga CA, Thaker G, Clementz BA. Auditory evoked oscillations discriminate major mood and psychotic diagnoses F1000research. 3. DOI: 10.7490/F1000Research.1090223.1  0.503
2012 Tamminga C. The Role of the Hippocampal Subfield System in Schizophrenia Psychosis Schizophrenia Research. 136. DOI: 10.1016/S0920-9964(12)70202-5  0.413
2011 Keshavan MS, Morris DW, Sweeney JA, Pearlson G, Thaker G, Seidman LJ, Eack SM, Tamminga C. A dimensional approach to the psychosis spectrum between bipolar disorder and schizophrenia: the Schizo-Bipolar Scale. Schizophrenia Research. 133: 250-4. PMID 21996268 DOI: 10.1016/J.Schres.2011.09.005  0.452
2011 Kozel FA, Rao U, Lu H, Nakonezny PA, Grannemann B, McGregor T, Croarkin PE, Mapes KS, Tamminga CA, Trivedi MH. Functional connectivity of brain structures correlates with treatment outcome in major depressive disorder. Frontiers in Psychiatry. 2: 7. PMID 21556277 DOI: 10.3389/Fpsyt.2011.00007  0.334
2011 Huang H, Prince JL, Mishra V, Carass A, Landman B, Park DC, Tamminga C, King R, Miller MI, van Zijl PC, Mori S. A framework on surface-based connectivity quantification for the human brain. Journal of Neuroscience Methods. 197: 324-32. PMID 21396960 DOI: 10.1016/J.Jneumeth.2011.02.017  0.31
2011 Ibrahim HM, Tamminga CA. Schizophrenia: Treatment targets beyond monoamine systems Annual Review of Pharmacology and Toxicology. 51: 189-209. PMID 20868275 DOI: 10.1146/Annurev.Pharmtox.010909.105851  0.414
2011 Tamminga CA. Domains of dysfunction in schizophrenia: implications for diagnosis. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 7: 34-5. PMID 18458770 DOI: 10.1002/J.2051-5545.2008.Tb00147.X  0.397
2011 Chandrasekaran A, Mears R, Ramaswamy S, Tandon N, Mudan A, Mitra P, Hajj MA, Hamil A, Nordin M, Wojcik J, McInnis M, Boutros N, Pearlson G, Sweeney J, Tamminga C, et al. Preliminary studies of altered synchronous gamma oscillatory activity in schizophrenia, bipolar disorder, and genetically high risk individuals under steady state response F1000research. 2. DOI: 10.7490/F1000Research.1658.1  0.419
2011 Skudlarski P, Schretlen D, Thaker G, Stevens M, Keshavan, Sweeney J, Tamminga C, Gill A, Fieldstone S, Pearlson G. White matter abnormalities in persons with schizophrenia and psychotic bipolar disorder and their relatives F1000research. 2. DOI: 10.7490/F1000Research.1419.1  0.434
2010 Tamminga CA, Stan AD, Wagner AD. The hippocampal formation in schizophrenia. The American Journal of Psychiatry. 167: 1178-93. PMID 20810471 DOI: 10.1176/Appi.Ajp.2010.09081187  0.327
2010 Shohamy D, Mihalakos P, Chin R, Thomas B, Wagner AD, Tamminga C. Learning and generalization in schizophrenia: effects of disease and antipsychotic drug treatment. Biological Psychiatry. 67: 926-32. PMID 20034612 DOI: 10.1016/J.Biopsych.2009.10.025  0.374
2010 Ivleva EI, Morris DW, Moates AF, Suppes T, Thaker GK, Tamminga CA. Genetics and intermediate phenotypes of the schizophrenia--bipolar disorder boundary. Neuroscience and Biobehavioral Reviews. 34: 897-921. PMID 19954751 DOI: 10.1016/J.Neubiorev.2009.11.022  0.421
2010 Castillo MA, Ghose S, Tamminga CA, Ulery-Reynolds PG. Deficits in syntaxin 1 phosphorylation in schizophrenia prefrontal cortex. Biological Psychiatry. 67: 208-16. PMID 19748077 DOI: 10.1016/J.Biopsych.2009.07.029  0.409
2009 Hesdorffer DC, Rauch SL, Tamminga CA. Long-term psychiatric outcomes following traumatic brain injury: a review of the literature. The Journal of Head Trauma Rehabilitation. 24: 452-9. PMID 19940678 DOI: 10.1097/Htr.0B013E3181C133Fd  0.303
2009 Lahti AC, Weiler MA, Holcomb HH, Tamminga CA, Cropsey KL. Modulation of limbic circuitry predicts treatment response to antipsychotic medication: a functional imaging study in schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 2675-90. PMID 19675535 DOI: 10.1038/Npp.2009.94  0.355
2009 Ghose S, Gleason KA, Potts BW, Lewis-Amezcua K, Tamminga CA. Differential expression of metabotropic glutamate receptors 2 and 3 in schizophrenia: a mechanism for antipsychotic drug action? The American Journal of Psychiatry. 166: 812-20. PMID 19487395 DOI: 10.1176/Appi.Ajp.2009.08091445  0.367
2009 Ghose S, Chin R, Gallegos A, Roberts R, Coyle J, Tamminga C. Localization of NAAG-related gene expression deficits to the anterior hippocampus in schizophrenia Schizophrenia Research. 111: 131-137. PMID 19403271 DOI: 10.1016/J.Schres.2009.03.038  0.365
2009 Uh J, Yezhuvath U, Mihalakos P, Tamminga C, Lu H. Perfusion Deficit in Schizophrenia and Correlation with Psychopathological Symptoms Neuroimage. 47. DOI: 10.1016/S1053-8119(09)71642-8  0.34
2008 Sellin AK, Shad M, Tamminga CA. Muscarinic agonists for the treatment of cognition in schizophrenia Cns Spectrums. 13: 985-996. PMID 19037177 DOI: 10.1017/S1092852900014048  0.387
2008 Tamminga CA. Accelerating new knowledge in schizophrenia American Journal of Psychiatry. 165: 949-951. PMID 18676597 DOI: 10.1176/Appi.Ajp.2008.08060815  0.387
2008 Conn PJ, Tamminga C, Schoepp DD, Lindsley C. Schizophrenia: moving beyond monoamine antagonists. Molecular Interventions. 8: 99-107. PMID 18403654 DOI: 10.1124/Mi.8.2.7  0.437
2008 Tamminga CA, Eberhard J, Tanghøj P. TOWARDS PERSONALIZED MEDICATION IN SCHIZOPHRENIA: HYPOTHESIS-GENERATING FINDINGS ON PREDICTORS OF TREATMENT RESPONSE AND WITHDRAWAL Schizophrenia Research. 102: 278. DOI: 10.1016/S0920-9964(08)70836-3  0.382
2008 Castillo MA, Ghose S, Tamminga C, Ulery-Reynolds PG. Deficits In Ck2-Mediated Syntaxin 1 Phosphorylation In Schizophrenia Schizophrenia Research. 102: 221. DOI: 10.1016/S0920-9964(08)70668-6  0.394
2008 Tamminga CA, Ghose S, Thomas B, Mihalakos P, Lu H. MEDIAL TEMPORAL CORTEX PATHOPHYSIOLOGY IN SCHIZOPHRENIA: ACTIONS OF ANTIPSYCHOTIC DRUGS Schizophrenia Research. 102: 19. DOI: 10.1016/S0920-9964(08)70063-X  0.389
2008 Ivleva E, Moates A, Cole D, Cheng P, Cullum M, Suppes T, Thaker G, Tamminga C. 5 – Neurophysiological and cognitive phenotypes across the schizophrenia–bipolar disorder boundary Schizophrenia Research. 98: 34-35. DOI: 10.1016/J.Schres.2007.12.072  0.305
2007 Ivleva E, Thaker G, Tamminga CA. Comparing Genes and Phenomenology in the Major Psychoses: Schizophrenia and Bipolar 1 Disorder Schizophrenia Bulletin. 34: 734-742. PMID 18515820 DOI: 10.1093/Schbul/Sbn051  0.383
2007 Shad MU, Keshavan MS, Tamminga CA, Cullum CM, David A. Neurobiological underpinnings of insight deficits in schizophrenia. International Review of Psychiatry (Abingdon, England). 19: 437-46. PMID 17671876 DOI: 10.1080/09540260701486324  0.424
2007 Geyer MA, Tamminga CA. Wayne Fenton's impact on academic neuroscience. Schizophrenia Bulletin. 33: 1156-9. PMID 17617663 DOI: 10.1093/Schbul/Sbm077  0.401
2007 Tamminga CA, Davis JM. The neuropharmacology of psychosis. Schizophrenia Bulletin. 33: 937-46. PMID 17562697 DOI: 10.1093/Schbul/Sbm063  0.424
2007 van Os J, Tamminga C. Deconstructing psychosis. Schizophrenia Bulletin. 33: 861-2. PMID 17545204 DOI: 10.1093/schbul/sbm066  0.305
2007 Freedman R, Carpenter WT, Davis JM, Goldman HH, Tamminga CA, Thomas M. The costs of drugs for schizophrenia. The American Journal of Psychiatry. 163: 2029-31. PMID 17151146 DOI: 10.1176/ajp.2006.163.12.2029  0.358
2006 Shad MU, Tamminga CA, Cullum M, Haas GL, Keshavan MS. Insight and frontal cortical function in schizophrenia: a review. Schizophrenia Research. 86: 54-70. PMID 16837168 DOI: 10.1016/J.Schres.2006.06.006  0.423
2006 Tamminga CA. Practical Treatment Information for Schizophrenia American Journal of Psychiatry. 163: 563-565. PMID 16585424 DOI: 10.1176/Appi.Ajp.163.4.563  0.37
2006 Erdely HA, Tamminga CA, Roberts RC, Vogel MW. Regional alterations in RGS4 protein in schizophrenia. Synapse (New York, N.Y.). 59: 472-9. PMID 16565965 DOI: 10.1002/Syn.20265  0.385
2006 Lahti AC, Weiler MA, Holcomb HH, Tamminga CA, Carpenter WT, McMahon R. Correlations between rCBF and symptoms in two independent cohorts of drug-free patients with schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 221-30. PMID 16123774 DOI: 10.1038/Sj.Npp.1300837  0.349
2006 Tamminga CA. The Neurobiology of Cognition in Schizophrenia The Journal of Clinical Psychiatry. 67: e11. DOI: 10.4088/Jcp.0906E11  0.402
2005 Akbarian S, Ruehl MG, Bliven E, Luiz LA, Peranelli AC, Baker SP, Roberts RC, Bunney WE, Conley RC, Jones EG, Tamminga CA, Guo Y. Chromatin alterations associated with down-regulated metabolic gene expression in the prefrontal cortex of subjects with schizophrenia. Archives of General Psychiatry. 62: 829-40. PMID 16061760 DOI: 10.1001/Archpsyc.62.8.829  0.334
2005 Holcomb HH, Lahti AC, Medoff DR, Cullen T, Tamminga CA. Effects of noncompetitive NMDA receptor blockade on anterior cingulate cerebral blood flow in volunteers with schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 30: 2275-82. PMID 16034443 DOI: 10.1038/Sj.Npp.1300824  0.378
2005 Lahti AC, Weiler MA, Medoff DR, Tamminga CA, Holcomb HH. Functional effects of single dose first- and second-generation antipsychotic administration in subjects with schizophrenia. Psychiatry Research. 139: 19-30. PMID 15950442 DOI: 10.1016/J.Pscychresns.2005.02.006  0.35
2005 Frost DO, Tamminga CA, Medoff DR, Caviness V, Innocenti G, Carpenter WT. Neuroplasticity and schizophrenia. Biological Psychiatry. 56: 540-3. PMID 15476682 DOI: 10.1016/J.Biopsych.2004.01.020  0.438
2005 Tamminga CA, Holcomb HH. Phenotype of schizophrenia: a review and formulation. Molecular Psychiatry. 10: 27-39. PMID 15340352 DOI: 10.1038/Sj.Mp.4001563  0.422
2005 Tamminga CA. Treating schizophrenia now and developing strategies for the next decade. Cns Spectrums. 6: 987-91, 1000. PMID 15311191 DOI: 10.1017/S1092852900001103  0.359
2005 Tamminga C. Partial Dopamine Agonists and the Treatment of Psychosis Current Neuropharmacology. 3: 3-8. DOI: 10.2174/1570159052773404  0.308
2004 Holcomb HH, Parwani A, McMahon RP, Medoff DR, Frey K, Lahti AC, Tamminga CA. Parametric study of accuracy and response time in schizophrenic persons making visual or auditory discriminations. Psychiatry Research. 127: 207-16. PMID 15296820 DOI: 10.1016/J.Psychres.2004.04.003  0.39
2004 Tamminga CA. The science of antipsychotics: mechanistic insight. Cns Spectrums. 8: 5-9. PMID 14978451 DOI: 10.1017/S1092852900008129  0.391
2004 Conley RR, Kelly DL, Richardson CM, Tamminga CA, Carpenter WT. The efficacy of high-dose olanzapine versus clozapine in treatment-resistant schizophrenia: a double-blind crossover study. Journal of Clinical Psychopharmacology. 23: 668-71. PMID 14624201 DOI: 10.1097/01.Jcp.0000096246.29231.73  0.362
2004 Lahti AC, Holcomb HH, Weiler MA, Medoff DR, Frey KN, Hardin M, Tamminga CA. Clozapine but not haloperidol Re-establishes normal task-activated rCBF patterns in schizophrenia within the anterior cingulate cortex. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 29: 171-8. PMID 14520337 DOI: 10.1038/Sj.Npp.1300312  0.346
2004 Geyer MA, Tamminga CA. Measurement and treatment research to improve cognition in schizophrenia: neuropharmacological aspects Psychopharmacology. 174: 1-2. DOI: 10.1007/S00213-004-1846-2  0.387
2003 Kelly DL, Conley RR, Richardson CM, Tamminga CA, Carpenter WT. Adverse effects and laboratory parameters of high-dose olanzapine vs. clozapine in treatment-resistant schizophrenia. Annals of Clinical Psychiatry. 15: 181-186. PMID 14971863 DOI: 10.1023/B:Acli.0000008171.90644.F8  0.32
2003 Tamminga CA, Lahti AC, Medoff DR, Gao XM, Holcomb HH. Evaluating glutamatergic transmission in schizophrenia. Annals of the New York Academy of Sciences. 1003: 113-8. PMID 14684439 DOI: 10.1196/Annals.1300.062  0.413
2003 Dwivedi Y, Rizavi HS, Conley RR, Roberts RC, Tamminga CA, Pandey GN. Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects. Archives of General Psychiatry. 60: 804-15. PMID 12912764 DOI: 10.1001/Archpsyc.60.8.804  0.301
2003 Lahti AC, Holcomb HH, Weiler MA, Medoff DR, Tamminga CA. Functional effects of antipsychotic drugs: comparing clozapine with haloperidol. Biological Psychiatry. 53: 601-8. PMID 12679238 DOI: 10.1016/S0006-3223(02)01602-5  0.348
2003 Schulz S, Lim K, Gruetter R, Medoff D, Tamminga C. High field MRS of glutamate and schizophrenia Schizophrenia Research. 60: 245-246. DOI: 10.1016/S0920-9964(03)81258-6  0.368
2003 Medoff D, Tamminga C, Lahti A, Holcomb H. Abnormal limbic system connectivity in schizophrenia Schizophrenia Research. 60: 228-229. DOI: 10.1016/S0920-9964(03)81211-2  0.311
2003 Cullen T, Beason-Held L, Tagamets M, Tamminga C, Holcomb H. Frontal and thalamic hypometabolism in schizophrenia Schizophrenia Research. 60: 216. DOI: 10.1016/S0920-9964(03)81174-X  0.306
2003 Tamminga C, Gao X, Medoff D, White A, Roberts R, Frost D. Regional hippocampal abnormalities in schizophrenia: RCBF and neurochemical changes are confined to the anterior portion Schizophrenia Research. 60: 67. DOI: 10.1016/S0920-9964(03)80584-4  0.403
2003 Tamminga CA, Schulz SC. International congress on schizophrenia research Schizophrenia Research. 60: 1. DOI: 10.1016/S0920-9964(03)80001-4  0.391
2002 Tamminga CA, Carlsson A. Partial dopamine agonists and dopaminergic stabilizers, in the treatment of psychosis Curr Drug Target Cns Neurol Disord. 1: 141-147. PMID 12769623 DOI: 10.2174/1568007024606195  0.319
2002 Tamminga CA, Nemeroff CB, Blakely RD, Brady L, Carter CS, Davis KL, Dingledine R, Gorman JM, Grigoriadis DE, Henderson DC, B Innis RB, Killen J, Laughren TP, McDonald WM, M Murphy GM, et al. Developing novel treatments for mood disorders: accelerating discovery. Biological Psychiatry. 52: 589-609. PMID 12361670 DOI: 10.1016/S0006-3223(02)01470-1  0.31
2002 Avila MT, Weiler MA, Lahti AC, Tamminga CA, Thaker GK. Effects of ketamine on leading saccades during smooth-pursuit eye movements may implicate cerebellar dysfunction in schizophrenia. The American Journal of Psychiatry. 159: 1490-6. PMID 12202268 DOI: 10.1176/Appi.Ajp.159.9.1490  0.333
2002 Tamminga CA. Partial dopamine agonists in the treatment of psychosis Journal of Neural Transmission. 109: 411-420. PMID 11956961 DOI: 10.1007/S007020200033  0.322
2002 Tamminga CA, Medoff DR, Cooper AM. Diseases of the mind and brain American Journal of Psychiatry. 159: 917. DOI: 10.1176/Appi.Ajp.159.6.917  0.321
2001 Medoff DR, Holcomb HH, Lahti AC, Tamminga CA. Probing the human hippocampus using rCBF: contrasts in schizophrenia. Hippocampus. 11: 543-50. PMID 11732707 DOI: 10.1002/Hipo.1070  0.406
2001 Lahti AC, Holcomb HH, Medoff DR, Weiler MA, Tamminga CA, Carpenter WT. Abnormal patterns of regional cerebral blood flow in schizophrenia with primary negative symptoms during an effortful auditory recognition task. The American Journal of Psychiatry. 158: 1797-808. PMID 11691685 DOI: 10.1176/Appi.Ajp.158.11.1797  0.378
2001 Schwarcz R, Rassoulpour A, Wu HQ, Medoff D, Tamminga CA, Roberts RC. Increased cortical kynurenate content in schizophrenia. Biological Psychiatry. 50: 521-30. PMID 11600105 DOI: 10.1016/S0006-3223(01)01078-2  0.409
2001 Lahti AC, Weiler MA, Tamara Michaelidis BA, Parwani A, Tamminga CA. Effects of ketamine in normal and schizophrenic volunteers. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 25: 455-67. PMID 11557159 DOI: 10.1016/S0893-133X(01)00243-3  0.371
2001 Tamminga CA, Frost DO. Changing concepts in the neurochemistry of schizophrenia. American Journal of Psychiatry. 158: 1365-1366. PMID 11532717 DOI: 10.1176/Appi.Ajp.158.9.1365  0.398
2001 Lahti AC, Warfel D, Michaelidis T, Weiler MA, Frey K, Tamminga CA. Long-term outcome of patients who receive ketamine during research. Biological Psychiatry. 49: 869-75. PMID 11343683 DOI: 10.1016/S0006-3223(00)01037-4  0.37
2000 Weiler MA, Thaker GK, Lahti AC, Tamminga CA. Ketamine effects on eye movements. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 23: 645-53. PMID 11063920 DOI: 10.1016/S0893-133X(00)00156-1  0.372
2000 Holcomb HH, Lahti AC, Medoff DR, Weiler M, Dannals RF, Tamminga CA. Brain activation patterns in schizophrenic and comparison volunteers during a matched-performance auditory recognition task. The American Journal of Psychiatry. 157: 1634-45. PMID 11007718 DOI: 10.1176/Appi.Ajp.157.10.1634  0.361
2000 Buckley PF, Buchanan RW, Tamminga CA, Schulz SC. Schizophrenia Research: A Progress Report, Summarizing Proceedings of the 1999 International Congress on Schizophrenia Research Schizophrenia Bulletin. 26: 411-419. PMID 10885640 DOI: 10.1093/Oxfordjournals.Schbul.A033462  0.435
2000 Gao XM, Sakai K, Roberts RC, Conley RR, Dean B, Tamminga CA. Ionotropic glutamate receptors and expression of N-methyl-D-aspartate receptor subunits in subregions of human hippocampus: effects of schizophrenia. The American Journal of Psychiatry. 157: 1141-9. PMID 10873924 DOI: 10.1176/Appi.Ajp.157.7.1141  0.365
2000 Tamminga CA, Vogel M, Gao X, Lahti AC, Holcomb HH. The limbic cortex in schizophrenia: focus on the anterior cingulate. Brain Research. Brain Research Reviews. 31: 364-70. PMID 10719164 DOI: 10.1016/S0165-0173(99)00053-3  0.387
2000 Tamminga C, Gao X, Lahti R, Vogel M. Pet-directed postmortem tissue analysis in schizophrenia Schizophrenia Research. 41: 31. DOI: 10.1016/S0920-9964(00)90369-4  0.367
1999 Tamminga CA. Neuroscience and schizophrenia. Biological Psychiatry. 46: 301-2. PMID 10435195 DOI: 10.1016/S0006-3223(99)00124-9  0.418
1999 Truffinet P, Tamminga CA, Fabre LF, Meltzer HY, Rivière ME, Papillon-Downey C. Placebo-controlled study of the D4/5-HT2A antagonist fananserin in the treatment of schizophrenia. The American Journal of Psychiatry. 156: 419-25. PMID 10080558 DOI: 10.1176/Ajp.156.3.419  0.382
1999 Tamminga CA. Serotonin and schizophrenia. Biological Psychiatry. 44: 1079-80. PMID 9836011 DOI: 10.1016/S0006-3223(98)00209-1  0.409
1999 Tamminga CA. Glutamatergic aspects of schizophrenia. The British Journal of Psychiatry. Supplement. 174: 12-15. DOI: 10.1192/S0007125000293598  0.412
1998 Lahti RA, Roberts RC, Cochrane EV, Primus RJ, Gallager DW, Conley RR, Tamminga CA. Direct determination of dopamine D4 receptors in normal and schizophrenic postmortem brain tissue: a [3H]NGD-94-1 study. Molecular Psychiatry. 3: 528-33. PMID 9857979 DOI: 10.1038/Sj.Mp.4000423  0.303
1998 Buchanan RW, Buckley PF, Tamminga CA, Schulz SC. Schizophrenia Research: A Biennium of Progress Proceedings From the Sixth International Congress on Schizophrenia Research Schizophrenia Bulletin. 24: 501-518. PMID 9853785 DOI: 10.1093/Oxfordjournals.Schbul.A033345  0.393
1998 Lahti RA, Cochrane EV, Roberts RC, Conley RR, Tamminga CA. [3H]Neurotensin receptor densities in human postmortem brain tissue obtained from normal and schizophrenic persons. An autoradiographic study. Journal of Neural Transmission (Vienna, Austria : 1996). 105: 507-16. PMID 9720978 DOI: 10.1007/S007020050074  0.308
1998 Tamminga CA, Buchanan RW, Gold JM. The role of negative symptoms and cognitive dysfunction in schizophrenia outcome. International Clinical Psychopharmacology. S21-6. PMID 9690966 DOI: 10.1097/00004850-199803003-00004  0.375
1998 Conley RR, Tamminga CA, Bartko JJ, Richardson C, Peszke M, Lingle J, Hegerty J, Love R, Gounaris C, Zaremba S. Olanzapine compared with chlorpromazine in treatment-resistant schizophrenia. The American Journal of Psychiatry. 155: 914-20. PMID 9659857 DOI: 10.1176/Ajp.155.7.914  0.345
1998 Tamminga CA. Schizophrenia and glutamatergic transmission. Critical Reviews in Neurobiology. 12: 21-36. PMID 9444480 DOI: 10.1615/Critrevneurobiol.V12.I1-2.20  0.413
1998 Lahti AC, Weiler MA, Corey PK, Lahti RA, Carlsson A, Tamminga CA. Antipsychotic properties of the partial dopamine agonist (-)-3-(3-hydroxyphenyl)-N-n-propylpiperidine(preclamol) in schizophrenia. Biological Psychiatry. 43: 2-11. PMID 9442338 DOI: 10.1016/S0006-3223(97)00030-9  0.37
1998 Lahti AC, Holcomb HH, Weiler MA, Medoff DR, Kile L, Michaelidis T, Fletcher S, Tamminga CA. Time course of rCBF changes after acute haloperidol in patients with schizophrenia Neuroimage. 7: S245. DOI: 10.1016/S1053-8119(18)31078-4  0.381
1998 Lahti A, Chen L, Warfel D, Corey P, Bartko J, Tamminga C. The factor structure for psychotic symptoms in patients with schizophrenia over three clinical states Schizophrenia Research. 29: 31-32. DOI: 10.1016/S0920-9964(97)88367-3  0.381
1997 Tamminga CA, Kane JM. Olanzapine (Zyprexa):characteristics of a new antipsychotic. Expert Opinion On Investigational Drugs. 6: 1743-1752. PMID 15989578 DOI: 10.1517/13543784.6.11.1743  0.34
1997 Kane JM, Tamminga CA. Sertindole (Serdolect): preclinical and clinical findings of a new atypical antipsychotic Expert Opinion On Investigational Drugs. 6: 1729-1741. PMID 15989577 DOI: 10.1517/13543784.6.11.1729  0.391
1997 Pandey GN, Conley RR, Pandey SC, Goel S, Roberts RC, Tamminga CA, Chute D, Smialek J. Benzodiazepine receptors in the post-mortem brain of suicide victims and schizophrenic subjects. Psychiatry Research. 71: 137-49. PMID 9271787 DOI: 10.1016/S0165-1781(97)00060-7  0.324
1997 Tamminga CA, Mack RJ, Granneman GR, Silber CJ, Kashkin KB. Sertindole in the treatment of psychosis in schizophrenia: Efficacy and safety International Clinical Psychopharmacology. 12. PMID 9179641 DOI: 10.1097/00004850-199702001-00005  0.348
1997 Zimbroff DL, Kane JM, Tamminga CA, Daniel DG, Mack RJ, Wozniak PJ, Sebree TB, Wallin BA, Kashkin KB. Controlled, dose-response study of sertindole and haloperidol in the treatment of schizophrenia American Journal of Psychiatry. 154: 782-791. PMID 9167505 DOI: 10.1176/Ajp.154.6.782  0.34
1997 Tamminga CA. The promise of new drugs for schizophrenia treatment. The Canadian Journal of Psychiatry. 42: 265-273. PMID 9114942 DOI: 10.1177/070674379704200304  0.318
1997 Weiler MA, Thaker GK, Lahti AC, Ross DE, Tamminga CA. Effects of ketamine on eye tracking in schizophrenia and controls Schizophrenia Research. 24: 246. DOI: 10.1016/S0920-9964(97)82707-7  0.357
1997 Lahti AC, Lahti RA, Carlsson A, Tamminga CA. The treatment of schizophrenia with partial dopamine agonist: A promising strategy Schizophrenia Research. 24: 207. DOI: 10.1016/S0920-9964(97)82595-9  0.376
1997 Conley RR, Tamminga CA, Beasley C. Olanzapine VS. chlorpromazine in therapy-refractory schizophrenia Schizophrenia Research. 24: 190. DOI: 10.1016/S0920-9964(97)82544-3  0.38
1997 Thoroughman KA, Weiler MA, Lahti AC, Tamminga CA, Holcomb HH. Implicit motor learning and memory in schizophrenia Schizophrenia Research. 24: 127. DOI: 10.1016/S0920-9964(97)82358-4  0.317
1996 LaPorte DJ, Lahti AC, Koffel B, Tamminga CA. Absence of ketamine effects on memory and other cognitive functions in schizophrenia patients. Journal of Psychiatric Research. 30: 321-30. PMID 8923336 DOI: 10.1016/0022-3956(96)00018-0  0.351
1996 Tamminga CA, Lahti AC. The new generation of antipsychotic drugs. International Clinical Psychopharmacology. 11: 73-6. PMID 8803664 DOI: 10.1097/00004850-199605002-00012  0.328
1996 Buckley PF, Buchanan RW, Schulz SC, Tamminga CA. Catching up on schizophrenia. The Fifth International Congress on Schizophrenia Research, Warm Springs, Va, April 8-12, 1995. Archives of General Psychiatry. 53: 456-462. PMID 8624189 DOI: 10.1001/Archpsyc.1996.01830050092014  0.424
1996 Lahti A, Weiler M, Corey P, Warfel D, Lahti R, Carlsson A, Tamminga C. Treatment of schizophrenia: New antidopaminergic strategies Biological Psychiatry. 39: 597. DOI: 10.1016/0006-3223(96)84276-4  0.392
1995 Tamminga CA, Holcomb HH, Gao XM, Lahti AC. Glutamate pharmacology and the treatment of schizophrenia: current status and future directions. International Clinical Psychopharmacology. 10: 29-37. PMID 8866763 DOI: 10.1097/00004850-199509000-00005  0.451
1995 Lahti AC, Koffel B, LaPorte D, Tamminga CA. Subanesthetic doses of ketamine stimulate psychosis in schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 13: 9-19. PMID 8526975 DOI: 10.1016/0893-133X(94)00131-I  0.39
1995 Carpenter WT, Tamminga CA. Why Neuroleptic Withdrawal in Schizophrenia Archives of General Psychiatry. 52: 192-193. PMID 7872843 DOI: 10.1001/Archpsyc.1995.03950150024003  0.346
1995 Carpenter WT, Conley RR, Buchanan RW, Breier A, Tamminga CA. Patient response and resource management: another view of clozapine treatment of schizophrenia. The American Journal of Psychiatry. 152: 827-32. PMID 7755110 DOI: 10.1176/Ajp.152.6.827  0.345
1995 Lahti AC, Tamminga CA. Recent developments in the neuropharmacology of schizophrenia. American Journal of Health-System Pharmacy : Ajhp : Official Journal of the American Society of Health-System Pharmacists. 52: S5-8. PMID 7749964 DOI: 10.1093/Ajhp/52.3_Suppl_1.S5  0.406
1995 Lahti AC, Holcomb HH, Medoff DR, Tamminga CA. Ketamine activates psychosis and alters limbic blood flow in schizophrenia. Neuroreport. 6: 869-72. PMID 7612873 DOI: 10.1097/00001756-199504190-00011  0.33
1995 Lahti RA, Lahti AC, Tamminga CA, Ranhosky, Kleber HD, Wise RA, Sethy. D2-family receptors in schizophrenia: Distribution and implications for treatment Clinical Neuropharmacology. 18: S110-S120. DOI: 10.1097/00002826-199501001-00013  0.35
1995 Lahti AC, Holcomb HH, Zhao M, Medoff DR, Tamminga CA. The glutamatergic system and schizophrenia Schizophrenia Research. 15: 157-158. DOI: 10.1016/0920-9964(95)95488-U  0.416
1995 Lahti A, Albert P, Warfel D, Lahti R, Tamminga C. Novel antidopaminergic strategies for the treatment of schizophrenia Schizophrenia Research. 15: 157. DOI: 10.1016/0920-9964(95)95487-T  0.401
1995 Pandey G, Pandey S, Conley R, Roberts R, Tamminga C. Benzodiazeprine receptors in human postmortem brain: Effect of schizophrenia, suicide, and neuroleptic drug treatment Schizophrenia Research. 15: 68. DOI: 10.1016/0920-9964(95)95214-T  0.379
1995 Conley R, Daviss S, Gounaris C, Tamminga C. Cavum septum pellucidum (CSP) in treatment resistant schizophrenia Schizophrenia Research. 15: 26. DOI: 10.1016/0920-9964(95)95092-N  0.372
1994 Conley R, Tamminga CA, Nguyen JA. Clinical Action of Remoxipride Archives of General Psychiatry. 51: 1001-1001. PMID 7979877 DOI: 10.1001/Archpsyc.1994.03950120073012  0.332
1994 Lahti A, Lahti R, Carlsson A, Tamminga C. The efficacy of the partial dopamine agonist (-)-3PPP in schizophrenia Biological Psychiatry. 35: 746. DOI: 10.1016/0006-3223(94)91131-2  0.375
1994 Carpenter WT, Buchanan RW, Kirkpatrick B, Tamminga C, Wood F. Neural Circuits in Schizophrenia-Reply Archives of General Psychiatry. 51: 516. DOI: 10.1001/Archpsyc.1994.03950070008004  0.409
1993 Holcomb HH, Cascella NG, Medoff DR, Gastineau EA, Loats H, Thaker GK, Conley RR, Dannals RF, Wagner HN, Tamminga CA. PET-FDG test-retest reliability during a visual discrimination task in schizophrenia Journal of Computer Assisted Tomography. 17: 704-709. PMID 8370824 DOI: 10.1097/00004728-199309000-00007  0.361
1993 Carpenter WT, Buchanan RW, Kirkpatrick B, Tamminga C, Wood F. Strong inference, theory testing, and the neuroanatomy of schizophrenia Archives of General Psychiatry. 50: 825-831. PMID 8215806 DOI: 10.1001/Archpsyc.1993.01820220081009  0.431
1993 Lahti A, Gao X, Cascella N, Mokriski B, LaPorte D, Lahti R, Tamminga C. Can NMDA antagonists help us understand the psychosis mechanism in schizophrenia? Schizophrenia Research. 9: 241-242. DOI: 10.1016/0920-9964(93)90541-P  0.39
1993 Lahti A, Cascella N, Conley R, Lahti R, Carlsson A, Tamminga C. Pharmacologic properties and antipsychotic effect of (-)-3PPP in schizophrenic patients Schizophrenia Research. 9: 241. DOI: 10.1016/0920-9964(93)90540-Y  0.306
1993 Conley R, Tamminga C, Nguyen JA, Hain R. Remoxipride therapy in treatment resistant schizophrenia Schizophrenia Research. 9: 235-236. DOI: 10.1016/0920-9964(93)90521-J  0.352
1992 Tamminga CA, Thaker GK, Buchanan R, Kirkpatrick B, Alphs LD, Chase TN, Carpenter WT. Limbic system abnormalities identified in schizophrenia using positron emission tomography with fluorodeoxyglucose and neocortical alterations with deficit syndrome. Archives of General Psychiatry. 49: 522-30. PMID 1627043 DOI: 10.1001/Archpsyc.1992.01820070016003  0.42
1992 Kirkpatrick B, Carpenter WT, Maeda K, Buchanan RW, Breier A, Tamminga CA. Plasma prolactin as a predictor of relapse in drug-free schizophrenic outpatients. Biological Psychiatry. 32: 1049-54. PMID 1467385 DOI: 10.1016/0006-3223(92)90067-A  0.312
1992 Pandey GN, Conley RR, Pandey SC, Tamminga C, Peretti F, Davis JM. Postmortem Brain 5Ht2 Receptors In Schizophrenia: Effect Of Neuroleptics And Suicide Clinical Neuropharmacology. 15. DOI: 10.1097/00002826-199202001-00103  0.357
1991 Carpenter WT, Buchanan RW, Breier A, Kirkpatrick B, Thaker G, Tamminga C. Psychopathology and the question of neurodevelopmental or neurodegenerative disorder. Schizophrenia Research. 5: 192-4. PMID 1760390 DOI: 10.1016/0920-9964(91)90067-2  0.316
1990 Thaker GK, Wagman AM, Tamminga CA. Sleep polygraphy in schizophrenia: methodological issues. Biological Psychiatry. 28: 240-6. PMID 1974153 DOI: 10.1016/0006-3223(90)90579-Q  0.312
1989 Schulz SC, Tamminga C. The second international congress on schizophrenia research. San Diego, California, April 1-5, 1989 Schizophrenia Research. 2: 2. DOI: 10.1016/0920-9964(89)90038-8  0.39
1989 Buchanan RW, Kirkpatrick B, Tamminga CA. Differential patterns of glucose metabolism in deficit and non-deficit schizophrenia Biological Psychiatry. 25: A99-A100. DOI: 10.1016/0006-3223(89)91687-9  0.361
1988 Tamminga CA, Burrows GH, Chase TN, Alphs LD, Thaker GK. Dopamine neuronal tracts in schizophrenia: their pharmacology and in vivo glucose metabolism. Annals of the New York Academy of Sciences. 537: 443-50. PMID 2904785 DOI: 10.1111/J.1749-6632.1988.Tb42126.X  0.332
1987 Tamminga CA, Tanimoto K, Kuo S, Chase TN, Contreras PC, Rice KC, Jackson AE, O'Donohue TL. PCP-induced alterations in cerebral glucose utilization in rat brain: blockade by metaphit, a PCP-receptor-acylating agent. Synapse (New York, N.Y.). 1: 497-504. PMID 2850626 DOI: 10.1002/Syn.890010514  0.347
1986 Foster NL, Tamminga CA, O'Donohue TL, Tanimoto K, Bird ED, Chase TN. Brain choline acetyltransferase activity and neuropeptide Y concentrations in Alzheimer's disease. Neuroscience Letters. 63: 71-5. PMID 3754039 DOI: 10.1016/0304-3940(86)90015-7  0.3
1986 Tamminga CA, Littman RL, Alphs LD, Chase TN, Thaker GK, Wagman AM. Neuronal cholecystokinin and schizophrenia: pathogenic and therapeutic studies. Psychopharmacology. 88: 387-91. PMID 3083460 DOI: 10.1007/Bf00180843  0.322
1986 Wong DF, Wagner HN, Tune LE, Dannals RF, Pearlson GD, Links JM, Tamminga CA, Broussolle EP, Ravert HT, Wilson AA, Toung JK, Malat J, Williams JA, O'Tuama LA, Snyder SH, et al. Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics. Science (New York, N.Y.). 234: 1558-63. PMID 2878495 DOI: 10.1126/Science.2878495  0.355
1986 Tamminga CA, Gotts MD, Thaker GK, Alphs LD, Foster NL. Dopamine Agonist Treatment of Schizophrenia With N-Propylnorapomorphine Archives of General Psychiatry. 43: 398-402. PMID 2869745 DOI: 10.1001/Archpsyc.1986.01800040108015  0.359
1983 Nurnberger JI, Jimerson DC, Simmons-Alling S, Tamminga C, Nadi NS, Lawrence D, Sitaram N, Gillin JC, Gershon ES. Behavioral, physiological, and neuroendocrine responses to arecoline in normal twins and "well state" bipolar patients. Psychiatry Research. 9: 191-200. PMID 6312479 DOI: 10.1016/0165-1781(83)90043-4  0.315
1982 Tamminga CA, Carpenter WT. The DSM-III diagnosis of schizophrenic-like illness and the clinical pharmacology of psychosis Journal of Nervous and Mental Disease. 170: 744-751. PMID 6128375 DOI: 10.1097/00005053-198212000-00005  0.433
1981 Tamminga CA, Tighe PJ, Chase TN, DeFraites EG, Schaffer MH. Des-tyrosine-gamma-endorphin administration in chronic schizophrenics. A preliminary report. Archives of General Psychiatry. 38: 167-8. PMID 7212942 DOI: 10.1001/Archpsyc.1981.01780270053006  0.324
1981 Tamminga CA, Schaffer MH. γ-Type Endorphins and Schizophrenia-Reply Archives of General Psychiatry. 38: 1182-1183. DOI: 10.1001/Archpsyc.1981.01780350116013  0.392
1979 Tamminga CA, Schaffer MH. Treatment of Schizophrenia with ergot derivatives. Psychopharmacology. 66: 239-242. PMID 119270 DOI: 10.1007/Bf00428312  0.347
1978 Tamminga CA, Crayton JW, Chase TN. Muscimol: GABA agonist therapy in schizophrenia. The American Journal of Psychiatry. 135: 746-7. PMID 350058 DOI: 10.1176/Ajp.135.6.746  0.333
1977 Pandey GN, Garver DL, Tamminga CA, Ericksen S, Ali SI, Davis JM. Postsynaptic supersensitivity in schizophrenia American Journal of Psychiatry. 134: 518-522. PMID 848578 DOI: 10.1176/Ajp.134.5.518  0.387
1977 Smith RC, Tamminga C, Davis JM. Effect of apomorphine on schizophrenic symptoms. Journal of Neural Transmission. 40: 171-176. PMID 323423 DOI: 10.1007/Bf01250567  0.371
Show low-probability matches.